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The Escherichia coli ParC protein is one of two subunits of the topoisomerase IV, a type II 
topoisomerase. Topo IV is responsible for relaxing positive supercoils and decatenating 
linked daughter chromosomes after replication. This is done by introducing transient 
double-stranded breaks into the DNA, passing through a segment of uncut duplex DNA, 
before resealing the break. Mutations in parC lead to the par phenotype which is 
characterized by chromosomes that can replicate but are deficient in chromosomal 
partitioning. ParC is thus essential for cell survival. ParC has been found to associate with 
the replication machinery in the cell. ParE, Topo IV´s second subunit, was in the same 
study not found along with ParC. The difference in localization of ParC and ParE is 
proposed to underlie a temporal regulation of Topo IV´s activity in the cell. The activity of 
ParC may also be stimulated by SeqA, a protein preventing overinitiation of chromosome 
replication, and it is suggested that this stimulation is mediated by a specific interaction of 
Topo IV and SeqA. 
 
In order to further look into ParC´s localization and function in the cell and to compare with 
SeqA´s assumed localization to the replication factory; both ParC and SeqA antibody were 
used in immunostaining followed by fluorescence microscopy. ParC antibody was, in 
opposition to SeqA antibody, not found to be localized as discrete foci and the co-
localization of ParC protein to the replication factory is thus uncertain. 
 
The ParC protein was purified in order to make an affinity column to purify the ParC 
antiserum used in the immunofluorescence microscopy. An expression plasmid was 
constructed by cloning the parC gene with a hexahistidine tag into a vector harbouring a T7 
promoter. The expression plasmid was transformed into an E. coli strain that expresses T7 
RNApolymerase. ParC protein was purified as a His-tagged protein by affinity 
chromatography based on the interaction between nickel and histidine, followed by 
gelfiltration.
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 Ab     Antibody 
 ATP    Adenosine triphosphate 
 BCA    Bicinchoninic acid 
 BLAST    Basic Local Alignment Search Tool 
 bp     Base pair 
 BSA    Bovine serum albumine 
 Da     Dalton 
 dH2O    Distilled water 
 dNTP    Deoxynucleotide triphospate (ATP, GTP, CTP, TTP) 
 et al.    et alibi (with others) 
 EtBr    Ethidium bromide 
 F     Farad  
 g     Gravity 
 IgG    Immunoglobulin G 
 In vitro    Process acting in a reaction tube 
 In vivo    Process acting in a living cell 
 kb     Kilobases 
 (l)     Liquid 
 M     Molar 
 OD     Optical density 
 Ω     Ohm 
 PAGE    Polyacrylamide gelelectrophoresis 
 rpm    Rounds per minute 
 U     Enzyme unit 
 UV     Ultraviolet 
 V     Volt  
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 M    mega    106
 k    kilo    103
 m    milli    10-3 
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The bacterium Escherichia coli belongs to the eubacteria group, one of two domains of 
prokaryotes in the living world. E. coli is a gram-negative, facultative anaerobe, non-spore-
forming rod, ~1-2 µm wide and 3-30 µm long, with peritrichous flagella. It classifies under 
the Enterobacteriaceae family. The E. coli genome is 4.7 x 106 base pair, and is a circular 
double-stranded molecule (Blattner et al., 1997). Most of the understanding of fundamental 
genetic mechanisms of life has come from studies of E. coli. Since some of these 
mechanisms are highly conserved throughout evolution, they are essentially the same in 
other prokaryotic and eukaryotic cells, and makes E. coli a commonly used model system. 
 
1.1 The E. coli cell cycle 
 
The cell cycle starts with DNA replication of the chromosome, then follows segregation of 
the daughter chromosomes and cell division by binary fission to form two identical 
daughter cells. Each daughter cell receives one copy of the cells genome.  
 
The cell cycle is divided into several periods (Helmstetter, 2007). The I period, 
interinitiation time, is the time required to prepare for initiation of replication. During 
balanced growth the interdivision time (τ), which is the same as generation time, is equal 
to, and determined by the interinitiation time. The C period includes the chromosome 
replication, which initiates at oriC, elongates bidirectionally along the chromosome and 
terminates in ter. The period from termination of replication to the end of cell division is 
the D period.  
 
The C and D periods are relatively constant, 40 minutes and 20 minutes respectively for 
cells with growth rates shorter than 60 minutes. For these cells the replication follows the 
 INTRODUCTION 
cell division (I = C+D). When duplication time exceeds 60 minutes (I > C+D), there is a 
period between cell division and initiation of replication termed the B period. Cells with 
doubling times above 60 minutes also have longer C and D periods (Skarstad et al., 
1983;Skarstad et al., 1985). Depending on the availability of nutrients, E. coli are able to 
adjust the growth rate and thereby the generation time. In rich medium E. coli can have a 
duplication time of 20 minutes (I < C). One important issue that distinguishes fast-growing 
cells from slow-growing cells is when τ is less than C+D. Then there is more than one 
origin at the time of initiation of replication, and replication starts at all origins essentially 
simultaneously (Skarstad et al., 1986). Since the C and D periods are relatively constant the 
initiation of replication must start before the previous round is completed. This results in a 
multiforked replication (Figure 1.1). 
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Figure 1.1 The cell cycle of E. coli during slow and rapid growth. During slow growth the initiation of 
replication occurs at one single origin. The replication (C period) and cell division (D period) completes 
within one generation (τ >C+D) and result in dividing cell with 2 origins. During rapid growth the cell 
initiates at four origins. The C+D periods in this example take almost 3 generations, and the result is dividing 
cells with eight origins. The picture was obtained from Trond Bachs Doctoral Thesis, 2005 
 
1.2 Replication 
 
The replication initiates in the oriC, which is located at 84.1 min on the genetic map. 
During replication, the strands in the DNA duplex are copied by base paring into two 
progeny identical duplexes (Kornberg and Baker, 1992). 
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1.2.1 Initiation of replication 
In rapidly growing cells there are several copies of oriC due to multiforked replication. 
Initiation of the origins occurs simultaneously, only once per cell cycle and the cells have, 
at any time 2n (n = 0, 1, 2, 3…) origins (Skarstad et al., 1986).  
  
The oriC region 
In order to start replication the duplex needs to unwind and the strands separate. These 
topological alterations have a starting point in the origin. There are several repeating DNA 
segments which are critical for oriC function (figure 1.2). The highly conserved 9-mer 
motif which is the binding site for the initiator protein DnaA (R1-R5 (M)) is repeated five 
times and controls the unwinding of DNA (DnaA boxes). The I-sites, I1-I3, are also DnaA 
binding sites. The 13-mer motif, repeated three times in the AT rich region located in the 
left part of oriC, is the initial site of strand separation. Other repeating sequences in oriC 
are eleven GATC sites where Dam methyl transferase adds methyl groups. SeqA, also bind 
to the GATC sites and inactivates newly replicated origins (von Freiesleben et al., 1994). In 
addition, there are binding sites for the DNA bending protein IHF, which assists in oriC 
unwinding, and the DNA bending protein Fis (Leonard and Grimwade, 2005). 
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 Figure 1.2 E. coli replication origin, oriC. GATC sites are found at 11 locations (underlined), R1-R5 and 
I1-I3 are DnaA binding sites. There are also a binding site for the proteins Integration Host Factor (IHF) and 
Factor for Inversion Stimulation (FIS). The DNA unwinding region contains 3 repeats of an AT-rich 13-mer 
sequence. The picture was obtained from Leonard and Grimwade, 2004 
 
 
Molecular events of initiation at oriC  
Upon initiation of replication the involved proteins assembles gradually at oriC and forms 
orisome complexes which together unwind DNA. When the initiator protein, DnaA is 
bound to ATP (not ADP), it interacts with DNA in the AT-rich region in the left part of 
oriC (figure 1.3). This interaction within the 13-mer region begins the unwinding of the 
DNA duplex and the initial complex is converted to an open complex. 
DnaA recruits a complex of DNA helicase, DnaB, and helicase loader DnaC. Both DnaB 
and DnaC are hexameric rings and bind ATP, and release of DnaC activates DnaB by ATP 
hydrolysis. DnaG primase interacts with DnaB helicase, resulting in the priming complex. 
DnaG primase synthesizes two short RNA primers, the dimeric complex of DNA 
polymerase III holoenzyme binds to the primers, and sliding clamps (a ring-shaped β-
subunit dimer of the DNA polymerase III) are assembled onto each primed template by a 
clamp loader (the polymerase III γ complex) (Kelman and O'Donnell, 1995) forming the 
replisome. DNA gyrase is required to relieve topological stress ahead of the replication 
forks, and together with SSB (Single-stranded DNA binding proteins) loaded, the 
replication can start (Messer and Weigel, 2007)  
 13
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Figure 1.3 Staged initiation at oriC in E. coli. I sites are not included in the figure (see text). The picture 
was obtained from Messer, 2002. 
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Sequestration and SeqA 
Sequestration is a mechanism in E. coli where newly replicated origins are prevented from 
re-initiating (Campbell and Kleckner, 1990). Dam methyl transferase, encoded by the dam 
gene recognizes 5′-GATC-3′ sites in the DNA double-strand and adds a methyl group to the 
adenine within every GATC site. The methylation occurs on unmethylated GATC sites 
which are generated after replication. At the time of replication initiation the adenine 
residues on both strands are methylated. This situation changes after replication because 
newly synthesized DNA strands are unmethylated, and since the old strand remains 
methylated this generates hemimethylated DNA.  
 
SeqA, a 21 kDa protein is non-essential to the cell. SeqA protein binds a minimum of two 
hemimethylated GATC sites and has a high affinity for fully methylated oriC (Brendler and 
Austin, 1999;Skarstad et al., 2000;Slater et al., 1995). SeqA is not bound to unmethylated 
oriC (Slater et al., 1995). The binding of SeqA to newly replicated hemimethylated oriC 
contributes to the ensuring that initiation occurs only once per cell cycle and 
simultaneously at all origins present in the cell (Boye et al., 2000). It is assumed that SeqA 
binding to hemi-methylated origins is necessary for sequestration (Lu et al., 1994). SeqA 
seems to have a role in folding of the chromosome (Fossum et al., 2003b) and most likely 
in chromosome segregation (Bach et al., 2003). It is also suggested that SeqA stimulates 
the relaxation and decatenation of TopoIV (Kang et al., 2003). 
 
1.2.2 Elongation and Termination 
Synthesis of DNA requires a coordination of several proteins to form a DNA replication 
fork.  
The replication forks move bidirectionally along the chromosome until they end up on the 
opposite side in the region called ter (terminus). Here the replication forks meet and 
terminate (Kornberg and Baker, 1992). 
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1.3 Chromosome segregation 
 
After the replication has terminated the chromosomes are catenated due to the DNA 
structure.  
In order to segregate the sister chromosomes the topologically constrained DNA needs to 
be decatenated. Topoisomerases, a class of enzymes, change the topological state of the 
molecule by introducing a transient break in the phosphodiester backbone, passing the 
DNA strand(s) through one another and reseal the break. 
 
1.3.1 Topoisomerases 
DNA topoisomerases regulate the number of topological links between two DNA strands 
by catalyzing transient single- or double-strand breaks, crossing the strands through one 
another and resealing the breaks (figure 1.4). Topoisomerases are classified as type I 
enzymes and type II enzymes, and both types exist in both prokaryotes and eukaryotes 
organisms.  
 
Type I topoisomerases (Topo I and Topo III) in E. coli introduces single-strand nicks.  
 
Type II topoisomerases consists of DNA gyrase and Topo IV. Both enzymes are composed 
of two subunits and both are essential for cell survival. The subunits of DNA gyrase, which 
is only present in prokaryotes, are named GyraseA and GyraseB, and the corresponding and 
homological subunits of Topo IV are ParC and ParE (Kato et al., 1990). 
These subunits combine into heterotetrameric complexes, gyrase A2BB2 and Topo IV 
ParC2E2, to form active enzymes. The GyrB subunit and the ParE subunit are functionally 
similar as both contain the ATPase domain. The GyrA subunit and the ParC subunit are 
also similar and contain the DNA binding domain. Even if DNA gyrase and Topo IV seem 
alike only DNA gyrase is able to negatively supercoil relaxed DNA (Peng and Marians, 
1995). ParC will be further explained below. 
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1.4 ParC and Topo IV 
 
The parC gene was identified, via a mutation in E. coli that resulted in a partitioning defect. 
The mutant cells showed abnormal chromosome segregation (Kato et al., 1988), and on 
background of showing defects in partition the gene was named parC. Mutations in parC or 
parE lead to the par phenotype. This phenotype is characterized by chromosomes that can 
be replicated but not partitioned. The result is accumulation of large nucleoids in the middle 
of cells at the non-permissive temperature.  
 
ParC protein is composed of 752 amino acids (2259 bp) and has a molecular weight of  
83 kDa. The native form of ParC is a homodimer and for ParE is a monomer. Topo IV may 
thus assemble in a stepwise fashion, i.e. ParC2 + ParE → ParC2ParE and ParC2ParE + ParE 
→ ParC2ParE2 (Peng and Marians, 1993b).  
 
ParC produces transient double-strand breaks and removes supercoils two at a time. 
ParC is organized with the N-terminal domain that covalently attaches to the DNA strand 
which has a double-strand break (DNA gate). It is through this DNA gate that the T-
segment must pass in order to change the superhelical density of the DNA substrate or 
decatenate sister molecules. In ParE the ATPase active site is at the N-terminal domain. 
The N-gate (figure 1.4) closes upon ATP binding and traps the T-segment on the DNA. 
ParE´s C-terminal domain is involved in the interaction with ParC.  
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Figure 1.4 Topoisomerase IV is a tetramer, and consists of 2 subunits ParE with a ATPase domain, here 
open and ready to capture the double-stranded DNA (T-segment). The T-segment will be transported through 
the ParC2 which has catalyzed a DNA break in the G-segment. After the strand in transported through the 
break ParC religates the break. The picture was obtained from I. Flåtten, Dept of Cell Biology, R-R HF  
 
1.4.1 ParC´s function in the cell 
In bacteria, successful cell division requires that the daughter chromosomes be disengaged 
topologically (decatenation), by the action of a topoisomerase, and that the daughter 
nucleoids be separated topographically (partition), one migrating to each of the daughter 
cells (Peng and Marians, 1993a;Peng and Marians, 1993b).  
 
Topoisomerase IV primarily decatenates DNA and relaxes positive supercoils where the 
circular chromosome are catenated, or linked, and that this occurs prior to the completion of 
DNA replication (figure 1.5) (Adams et al., 1992;Peng and Marians, 1993a;Peng and 
Marians, 1993b). 
 
The decatenating activity happens as Topo IV catalyzes the ATP dependent passage of one 
DNA segment (the transport, or T-segment) through another segment (the gate, or G-
 18
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segment) (figure 1.4) and reseals the break. Topo IV Superhelical DNA relaxation requires 
both ParC and ParE (Kato et al., 1992). 
 
 
 
 
Figure 1.5 a) Relaxing action of Topo IV, which involves a double-strand break (indicated by a short line), 
allowing the tangeled segment to pass through. The break is then resealed. b) The decatenation, where Topo 
IV makes a double-strand break in one DNA molecule (the black one), allowing the other molecule to pass 
through. The break is then resealed.  The picture was obtained from I. Flåtten, Dept of Cell Biology, R-R HF 
 
1.4.2 ParC´s localization in the cell 
It has been proposed that ParC localizes to the replication machinery and observations have 
linked Topo IV to the DNA polymerase III holoenzyme (HE) as well as other proteins (se 
below). Examination by immunostaining followed by fluorescence microscopy have 
localized ParC as discrete foci both between the nucleoid masses and on the DNA (Espeli 
et al., 2003). 
 
ParE seems to be appearing at the poles and in the center of the cell (Espeli et al., 2003). 
This can indicate that Topo IV activity is regulated by separate localization of the subunits 
and that active Topo IV is suppressed until late in the cell cycle. It is not until ParC is 
disassembled from the replication factory that it is free to interact with ParE. The activity is 
restricted until the two daughter chromosomes are segregated (Espeli et al., 2003). ParC 
localization in the cell are however uncertain and one of the aims of this thesis. 
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1.4.3 Interaction with SeqA 
SeqA protein which prevents overinitiation of chromosome replication has been suggested 
to also participate in the segregation of chromosomes (Kang et al., 2003).  
It is shown that SeqA interacts with the C-terminal part of ParC and that SeqA stimulates 
Topo IV activity both in relaxing supercoiled plasmid DNA and converting catenanes to 
monomers. Earlier microscopy of immunolabeled SeqA has shown that SeqA is 
predominantly localized in foci situated at the replication forks. Here SeqA binds to newly 
replicated DNA and might contribute to proper segregation of daughter chromosomes 
(Bach et al., 2003;Fossum et al., 2003a;Fossum et al., 2003b). Excess SeqA protein delays 
nucleoid segregation and cell division (Bach et al., 2003). 
 
1.4.4 Interaction with other proteins 
Another identified protein possibly interacting with ParC is FtsK. It is shown that FtsK 
stimulates the decatenation activity of Topo IV (Espeli et al., 2003). FtsK resides at the 
septum and aids in transportation of DNA to the correct cell halves. Espeli et al. proposed 
that FtsK contributed to concentrate ParC to the cell centre by the capture of ParC after the 
replication fork was disassembled. 
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1.5 Aims of the study 
 
The localization of the ParC protein, its, if any, function at the replicationfork and the 
possible relationship with other proteins there, is not completely understood. 
A previous investigation has shown that ParC colocalizes to the replication factory by 
interacting with DNA polymerase III holoenzyme and thereby forming discrete foci. 
Temporary evidence for this is reported by Espeli et al. I wanted to further confirm ParC 
protein’s localization in E. coli cells.  
 
The ParC protein has been found to interact with SeqA protein, where SeqA stimulates the 
activities of Topo IV, both in relaxing supercoiled plasmid DNA and decatenation of 
daughter chromosomes. In order to find out whether their localization in the cell were 
comparable I wanted to look at SeqA foci together with ParC foci. 
 
The main objective of this study was to find out whether ParC colocalizes with SeqA at the 
replication factory. 
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2.1 Growth conditions and storage of cells 
 
6 ml LB medium was inoculated with a bacterial strain and 50 μg/ml ampicillin and  
30 μg/ml chloramphenicol. The cells were grown for around 16 hours at 37°C. To ensure 
that the culture is adequately aerated, the volume of the culture should be at least four times 
greater than the volume of the bacterial culture. The tube should be loosely capped and the 
culture should be incubated with vigorous shaking. Overnight cultures are diluted 1:500 in 
fresh medium, containing the same amount of antibiotics and grown to exponentially phase 
at 37°C with vigorous shaking. To monitor growth mass optical density (OD) was 
measured at 450 nm for AB minimal medium or 600 nm for LB medium with a 
spectrophotometer. 
 
2.2 Standard DNA techniques 
 
2.2.1 DNA plasmid purification  
(Sambrook and Russell, 2001) 
 
Alkaline lysis in combination with the detergent SDS is used to isolate plasmid from  
E. coli. Exposure of bacterial suspensions to the strongly anionic detergent at high pH 
opens cell wall, denatures chromosomal DNA and proteins, and releases plasmid DNA into 
the supernatant. The alkaline solution completely disrupts base pairing, but since the 
strands of closed circular plasmid are topologically intertwined they will not separate. 
When the pH is returned to neutral the two strands fall back into register as long as the 
intensity and duration of exposure to OH− is not too great.  
 METHODS 
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The denatured DNA, broken cell walls and bacterial proteins form large complexes that are 
coated with dodecyl sulfate. By replacing the sodium ions with potassium ions the 
complexes are efficiently precipitated from solution. After centrifugation native plasmid 
DNA can be recovered from the supernatant. 
 
The plasmid DNA recovered from the lysate can be purified in many different ways and to 
different extend, according to the needs of the experiment. Small scale and large scale DNA 
plasmid purifications are described in appendix 2 and 3. 
 
2.2.2 Purification of DNA from gel bands  
(Sambrook and Russell, 2001) 
 
PCR products are commonly purified to remove excess nucleotides and primers. In 
preparation for cloning the DNA fragments need to be purified. This membrane-based 
system allows recovery of isolated DNA fragments or PCR products. 
The principle for purification of DNA from gel bands is based on the ability of DNA to 
bind to silica membranes in the presence of chaotropic salts. Guanidine isothiocyanate is a 
strong chaotropic agent because it contains a reductant to break protein disulphide bonds 
and potent cationic and anionic groups that form strong hydrogen bonds. Hydrogen 
bonding profoundly affects the secondary structure of polymers such as DNA, RNA, and 
proteins, as well as how water-soluble a molecule is. Under native conditions, nucleic acids 
are covered by a hydrate shell consisting of water molecules that maintain the solubility of 
DNA in aqueous solutions. With the addition of chaotropic ions to the nucleic acid, this 
relatively ordered structure of water molecules of the hydrate shell is destroyed. The 
chaotropic salts create a hydrophobic environment. Under these hydrophobic conditions, 
the silica membrane column is the most suitable binding partner for the nucleic acids. 
Proteins, metabolites, and other contaminants do not bind to the membrane and therefore 
are washed away during the subsequent washing steps. As a further feature of the 
chaotropic salts, the respective cations saturate the silica membrane with positive charges, 
 METHODS 
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which still improves the binding of nucleic acids under hydrophobic conditions. The high 
concentration of salt also facilitates binding of the nucleic acids DNA and RNA to the silica 
membrane in the column. The protocols describing the reaction are listed in appendix 4. 
 
2.2.3 Quantification of DNA 
(Sambrook and Russell, 2001) 
 
The Hoefer® DyNA Quant 200 Fluorometer and Hoechst 33258 fluorescent dye were used 
to quantify DNA preparations of unknown concentration. Calf thymus DNA was used as a 
double stranded DNA standard. Hoechst 33258 binds to the AT-rich region and with high 
specificity into the minor groove of double stranded DNA. Hoechst 33258 excites in the 
near UV (350 nm) and emits at 458 nm, and when it is bound to an unknown sample and a 
DNA standard the concentration of the sample can be estimated by comparing the 
intensities of fluorescence.  
 
An assay solution containing 0.1 μg/ml Hoechst 33258 in 1 x TNE- buffer was mixed with 
1/1000 volume DNA sample or 1/1000 volume DNA standard (100 μg/μl). 
 
2.2.4 Agarose gel electrophoresis 
(Sambrook and Russell, 2001) 
 
Electrophoresis through agarose is used to separate, identify and purify DNA fragments. 
Agarose is a polysaccharide isolated from seaweed. It is composed of alternating residues 
of D- and L-galactose joined by α-(1→3) and β-(1→4) glycosidic linkages (figure 7.1) 
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Figure 7.1 Agarose consists of repeating monomers of 3, 6-anhydro-L-galactose and D-galactose. Agarose 
is a polysaccharide isolated from seaweed.  
The figures was obtained from www.bioc.unizh.ch/.../agar/agarose.jpg  and  
 agtcbioproducts.com/images/agarose01.jpg. 
 
Gelation of agarose results in a three-dimensional mesh of channels whose diameters range 
from 50 nm to 200 nm. DNA from about 200 basepairs to approximately 50 kb in length 
can be separated on agarose gels of various concentrations (standard: 0.5-1.5 %)  
 
Small DNA fragments are best resolved in agarose gels run in horizontal configurations, 
with an electric field of constant strength and direction. 
The rate of migration of DNA through the gel depends upon several factors. Larger 
molecules migrate slowly because of greater frictional drag and because they worm their 
way through the gel less efficiently than smaller molecules. The type and concentration of 
agarose, the strength of applied voltage, the composition and ionic strength of 
electrophoresis buffer all affect the mobility of DNA. Superhelical circular and linear 
DNAs migrate through agarose gels at different rates. Under some conditions superhelical 
circular DNA migrates faster than linear DNA, under other conditions the order is reversed. 
 
The DNA bands on agarose can only be visualized if they are labeled or stained in 
someway. One method is to expose DNA to the dye ethidium bromide (EtBr), which 
fluorescence under UV light when it is bound to DNA. Protocol is listed in appendix 5. 
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2.3 Cloning in E. coli 
(Alberts et al., 2002) 
 
DNA cloning is a term, which in cell biology is used in two senses. In one sense it refers to 
the amplification of a DNA molecule. However, the term is also used to describe the 
isolating of one DNA sequence in order to create many identical copies of this particular 
gene. The cloning process can be accomplished in several ways. In this thesis a DNA 
fragment was inserted into a cloning vector, and the DNA propagated by insertion into it is 
said to have been cloned 
 
2.3.1 The polymerase chain reaction (PCR) 
(Alberts et al., 2002) 
 
PCR is an in vitro technique where selected regions of DNA are amplified a billion fold. 
Two sets of DNA primers (oligonucletides), chosen to flank the desired nucleotide 
sequence of the gene, are synthesized by chemical methods. In this thesis one of the 
primers, ParC F NcoI-His (table A1.2) contains a molecular tag of 6 amino acids histidine 
(His-tag). The His-tag, which is placed in N-terminus of the recombinant protein, is used in 
order to be able to purify the proteins using column chromatography (appendix 19). The 
two primers are then used to prime DNA synthesis on single strands generated by heating 
the DNA from the entire genome. The newly synthesized DNA is produced in a reaction 
catalyzed in vitro by a purified DNA polymerase, and the primers remain at the 5´ends of 
the final DNA fragments that are made. 
Nothing special is produced in the first cycle of DNA synthesis; the power of the PCR 
method is revealed only after repeated rounds of DNA synthesis. Every cycle doubles the 
amount of DNA synthesized in the previous cycle. Because each cycle requires a brief heat 
treatment to separate the two strands of the template double helix, the technique requires 
the use of a special DNA polymerase. Taq polymerase, isolated from the thermophilic 
bacterium Thermus aquaticus, catalyzes template-dependant synthesis of DNA and is the 
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enzyme most frequently used. A version of Taq, AmpliTaq Gold™ DNA polymerase, 
which is used in this thesis, requires heat activation to generate polymerase activity. Taq 
polymerase is stable at a much higher temperature than normal, so that it is not denatured 
by the repeated heat treatments. With each round of DNA synthesis, the newly generated 
fragments serve as templates in their turn, and within a few cycles the predominant product 
is a single species of DNA fragment whose length corresponds to the distance between the 
two original primers.  
 
The DNA oligonucletides to prime DNA synthesis requires careful design to obtain the 
desires products in high yield. Other components are equimolar amounts of dATP, dTTp, 
dCTP and dGTP, free divalent cations - usually Mg2+, buffer to maintain pH, monovalent 
cations – usually KCl and template DNA. Template DNA containing target sequences can 
be added to PCR in single- or double-stranded form. 
 
PCR is an iterative process consisting of 3 elements. First the DNA template is denatured to 
separate the double-strand helix. The temperature is determined in part of their GC content. 
The higher the GC content, the higher the temperature required. Annealing temperature, an 
important parameter in PCR, is adjusted according to GC content. Stability of the duplex is 
a direct function of the number of triple-hydrogen-bounded GC base pairs it contains; the 
larger the mole fraction of GC pairs, the higher the temperature of melting. In thermal 
melting, unwinding of the chains begin in regions high in AT base pairs, and proceeds to 
regions of progressively higher GC content (Kornberg and Baker, 1992).The time is 
determined partly by the length of the molecule. Annealing of primers to single-stranded 
target sequence requires the correct temperature. To optimize the annealing conditions the 
thermal cycler can be programmed to touchdown PCR. This involves using progressively 
lower annealing temperatures in consecutive pairs of cycles but having identical conditions 
in all other respects. Extension of the annealed primers by a thermostable DNA polymerase 
is carried out at or near the optimal temperature for DNA synthesis. The number of cycles 
required for maximum yield of amplification product is generally 30 cycles. The reaction 
was carried out as described in appendix 6. 
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2.3.2 Digestion of DNA by restriction nucleases 
(Alberts et al., 2002) 
 
Restriction nucleases are different enzymes made of different bacteria. They are used as 
protection against virus infection by digestion and degrading of viral DNA. These enzymes 
can be purified from the bacteria, cut the DNA double helix at certain sites specified by the 
local nucleotide sequence, and cleave double-stranded DNA molecules into fragments.  
Each nuclease recognizes a specific sequence of four to eight nucleotides in DNA. 
Different restriction nucleases have different sequence specificities, making it simple to 
create a DNA fragment of strictly defined size, including a particular gene.  
The bacteria’s own genome is protected from cleavage by methylation at an A or a C 
residue. The sequences in foreign DNA are generally not methylated and will be cleaved. 
Some restriction nucleases produce staggered cuts, which leave short single-stranded tails 
at the two ends of each fragment. These ends are called cohesive ends since they form 
complementary base pairs with ends of other fragments cut by the same restriction nuclease 
or another enzyme that creates the same cohesive ends. Other restriction nucleases produce 
blunt ends which mean there are no single-stranded tails at the end of the fragment. 
 
Recombinant DNA molecules are produced by splicing together complementary fragments 
with the enzyme DNA ligase as described in paragraph 2.3.3. 
 
For complete digestion, 1 unit of restriction nuclease is required to digest 1 μg of substrate 
DNA in 1 hour. Supercoiled plasmids generally require more than 1 unit enzyme per μg 
DNA to be cleaved completely. The reaction was carried out as described in appendix 7. 
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2.3.3 Ligation 
(Alberts et al., 2002;Sambrook and Russell, 2001)(pGEM®-T Easy Vector Instructions for 
use of products, Promega) 
 
DNA ligase is an enzyme that creates covalent phosphodiester bonds between 3` hydroxyl 
end of one nucleotide with 5` phosphate end of another. For its catalytic activity the 
enzyme requires the presence of ATP and Mg2+. Ligase can link cohesive ends and blunt 
ends as well as creating a final phosphodiester bond in single strand breaks to fully repair 
the DNA. 
 
T4 DNA ligase is used in most experiments and is isolated from bacteriophage T4. The 
optimal enzyme temperature is a balance of melting temperature and annealing temperature 
of the DNA fragments being ligated. 
 
The molar ratio of insert DNA fragment to plasmid vector should be ~ 2:1 in the ligation 
reaction. The ideal volume for the reaction is 20 μl and is carried out at 16ºC over night or 
for 1 hour at room temperature. In the ligation reaction using pGEM-T Easy Vector the 
ideal volume was 10 μl. The reactions are described in appendix 7 and 13. 
 
2.3.4 Transformation  
(Madigan et al., 2002;Sambrook and Russell, 2001) 
 
In order to see the genetic change the recombinant molecule needs to be incorporated into a 
recipient cell. Cells that are able to take up DNA molecules and be transformed are said to 
be competent. One way to induce competence to E. coli is to treat the cells with high 
concentrations of calcium ions which make chemically competent cells. How the cells take 
up the DNA is not exactly known. Another technique is electroporation, were the cells are 
exposed to pulsed electrical fields.  The cells plasma membranes are partly disrupted to 
make them more permeable and the DNA enter the cells through the small transient pores 
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before resealing. This method is temperature-dependent and is best carried out at 0-4 °C. 
This method gives electrocompetent cells. Ultracompetent cells are chemically competent 
cells which apparently have higher transformation efficiency. Preparation of the different 
competent cells, the respectively transformation and the selection of transformants are 
described in appendix 8-12 and appendix 14. 
 
2.3.5 Subcloning 
(Sambrook and Russell, 2001)(pGEM®-T Easy Vector Instructions for use of products, 
Promega) 
 
 The pGEM®-T Easy Vector System are systems for subcloning of PCR products. The 
vector is prepared by cutting the pGEM®-T Easy Vector with EcoR V and adding a 3` 
terminal thymidine to both ends. These single 3`-T overhangs at the insertion site greatly 
improve the efficiency of ligation of a PCR product into the plasmid by preventing 
recirculization of the vector. Certain thermostable polymerases provide a compatible 
overhang by adding a single deoxyadenosine to the 3′- ends of the amplified fragments. 
pGEM®-T Easy Vector contain T7 RNA polymerase promoter flanking a multiple cloning 
region within the α-peptide coding region of the enzyme β-galactosidase.  
α-complementation occurs when two inactive fragments of E. coli β-galactosidase 
associate to form a functional enzyme. β-galactosidase is encoded by the lacZ gene and the 
enzyme cleaves the disaccharide lactose into the monosaccharides glucose and galactose. 
Neither plasmid-encoded fragments of β-galactosidase nor the host-encoded fragments of 
β-galactosidase are themselves active, but they can associate to form an enzymatically 
active protein. The lac+ bacteria that result from α-complementation form blue colonies in 
the presence of the chromogenic substrate X-gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside), because X-gal is converted by the enzyme into an insoluble dense blue 
compound. When parC-His is inserted into the pGEM®-T Easy Vector the transformed 
bacteria will appear as white colonies. This is because the lacZ gene is disrupted by 
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insertion so that no plasmid-encoded fragment of β-galactosidase can be formed to join the 
host-encoded fragment of β-galactosidase. The protocol is listed in appendix 13. 
 
2.4 DNA sequencing and sequence alignment  
(Alberts et al., 2002) 
 
DNA sequencing, which is originally based on Sanger’s method of sequencing use the 
dideoxy method where in vitro DNA synthesis is performed in the presence of chain-
terminating dideoxyribonucleoside triphosphates (ddNTP). This derivative of a normal 
ddNTP lacks the 3΄ hydroxyl group that allows for strand extension in the 5΄- 3΄ direction. 
When purified DNA is synthesized in vitro in a mixture that contains single-stranded 
molecules of the DNA to be sequenced, DNA polymerase, a primer, the four dNTPs and a 
small amount ddNTP, incorporation of ddNTP will terminate the growing DNA chain. This 
is because the lacking 3΄OH group will block the next nucleotide. The reaction mixture 
contains both normal dNTPs and ddNTP, which leads to a competition between chain 
extension and infrequent, but base-specific, termination. 
Accordingly, this reaction mixture will eventually produce, at random, a set of DNA 
fragments of different lengths. The complete reaction is run on a polyacrylamide gel which 
separates the fragments differing by only one nucleotide. To facilitate separation, the chain-
terminating nucleotides are each labeled with a different colored fluorescent dye, the 
reactions can be performed in the same tube and the products be separated in a single lane 
on the gel. A detector positioned near the bottom of the gel reads and records the color of 
the fluorescent label on each band as it passes through a laser beam. A computer then reads 
and stores the nucleotide sequence. 
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2.4.1 Sequence alignment 
Alignment of the sequence of parC-His insert and 4 different primers was performed using 
GATC Biotech http://www.gatc-biotech.com/en/index.php and Blast 2 Sequences 
http://www.ncbi.nlm.nih.gov/BLAST/bl2seq/wblast2.cgi
 
2.5 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and detection of 
proteins by immunoblot analysis 
(Alberts et al., 2002) 
 
Proteins have, depending on the mixture of the amino acids they contain, a net positive or 
negative charge. When an electric field is applied to a solution of proteins, the protein 
migrates at a rate depending on its net charge, its size and shape. This technique is 
electrophoresis and is the basis for SDS-PAGE.  
Polyacrylamide gels are composed of chains of polymerized acrylamide that are highly 
cross linked by N,N΄-methylene-bis-acrylamide. The pore size of the gel can be adjusted, by 
the amount of acrylamide, to “fit” the protein molecule of interest. Ammonium persulphate 
(APS) is a strong radical initiator and catalyze the polymerization of acrylamide and 
bisacrylamide. TEMED (N,N,N΄,N΄-tetramethylethylenediamine) is used with APS to 
contribute to the same polymerization. In order to load the proteins onto the gel they must 
unfold into extended polypeptide chains, and be released from other proteins or lipid 
molecules. Sodium dodecyl sulfate (SDS), which is an anionic detergent, binds to the 
hydrophobic regions of the proteins and render them freely soluble in detergent solution. In 
addition, the reducing agent β-mercaptoethanol is added to break any S-S linkages in the 
proteins. Polypeptides of equal size bind the same amount of SDS, attain similar negative 
charge and migrate towards the positive electrode, through the gel, with equal rate. The 
polyacrylamide gel, which acts as a molecular sieve, retards the large molecules more than 
the small one. As a result, a mixture of proteins is fractionated into a series of discrete 
bands arranged in order of molecular weight, which can be identified with a marker. The 
protocols are listed in appendix 16 and 17. 
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In detection of proteins by immunoblot analysis, a semidry blotting was used to transfer the 
proteins from the gel to a polyvinylidene difluoride (PVDF) membrane. In order to block 
unspecific binding sites on the membrane, the membrane was soaked in low-fat dried milk 
in TBS-T. Then irrelevant proteins from the milk could bind to the unspecific binding sites. 
This eliminated some background signals so that the immunoblotting could be more 
sensitive. First the membrane was incubated with primary antibody that bound to the 
protein of interest (figure 7.3). Then the membrane was incubated with a secondary alkaline 
phosphatase-linked antibody specific for the primary antibody, followed by addition of 
ECF substrate. The alkaline phosphatase catalyses the conversion of ECF, by cleaving a 
phosphate group from the ECF substrate to yield a highly fluorescent product which 
fluoresces at 550-570 nm. Protocols are listed in appendix 18. 
 
 
Fluorescence at 550-570 nm 
 
 
 
 
 
 
 
Figure 7.3 Schematic diagram of the ECF Western blot detection.  
Orange symbol, target protein; purple symbol, primary antibody; red and pink symbol, secondary antibody 
with linked phosphatase; blue circles, ECF substrate; blue triangles, phosphate group. The picture was 
obtained from  
http://www4.gelifesciences.com/applic/upp00738.nsf/vLookupDoc/193300141B500/$file/AppNote_6
8.pdf 
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2.5.1 Measurement of total protein content 
(BCA Protein Assay Kit, PIERCE) 
 
The Pierce BCA Protein Assay is based on bicinchoninic acid (BCA) for the colorimetric 
detection and quantification of total protein. This method combines the reduction of Cu2+ to 
Cu1+ by protein in an alkaline medium with the binding of Cu1+ to BCA which results in the 
formation of a BCA-Cu1+ complex which exhibits a strong absorbance at 562 nm that is 
nearly linear with increasing protein concentrations over a broad range of 20 µg/ml to 2 000 
µg/ml protein. The protocol is listed in appendix 16. 
 
2.6 Expression of ParC protein 
(Sambrook and Russell, 2001) 
 
Expression of cloned genes is done to identify and characterize the recombinant protein 
they encode. The vector pET-16b contains a T7 promoter, and expression of a gene cloned 
into the T7 vector requires transformation into competent cells containing the T7 RNA 
polymerase gene, which BL21-Gold(DE3)pLysS does. 
 
The plasmid vector pET-16b contains the lacI gene encoding the lac repressor. The lac 
repressor prevents transcription from the promoter in the absence of an inducer. When 
IPTG (isopropyl-β-D-thiogalactopyranoside) is added, the repressor will be unable to bind 
to the promoter and transcription of the gene starts accordingly.  
 
IPTG (isopropyl-beta-D-thiogalactopyranoside) is a highly stable synthetic analog of 
lactose. It inactivates the lac repressor and induces synthesis of β-galactosidase, an enzyme 
that promotes lactose utilization. The IPTG is used to induce the expression of cloned genes 
which are under control of the lac operon. It is used in conjunction with X-Gal to determine 
the lac phenotype in blue/white colony screening. 
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X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-galacto-pyranoside) is an inert chromogenic 
substrate for β-galactosidase. β-galactosidase hydrolyzes X-Gal into a colorless galactose 
and 4-chloro-3-brom-indigo, which forms an intense blue precipitate. Induction of the lacZ 
gene with IPTG leads to the hydrolysis of X-Gal and to the development of blue colonies. 
Protocol is listed in appendix 15. 
 
2.6.1 Inclusion bodies  
(Sambrook and Russell, 2001) 
 
Most nonsecreted proteins synthesized in E. coli accumulate as denatured aggregates, 
called inclusion bodies. The formation of inclusion bodies is influenced by the nature of the 
protein, by the host cell and by the level of expression resulting from the vector choice and 
the growth and induction conditions. Inclusion bodies can be purified by differential 
centrifugation. 
These aggregates are insoluble in aqueous buffers at neutral pH, but they usually can be 
dissolved in buffers that are markedly acidic or alkaline, or contain high concentrations of 
detergent, organic solvents or denaturants. In a few cases it has been possible to fold the 
solubilized protein in vitro into an active or native state. The protocol is described in 
appendix 19. 
 
2.7 Purification of ParC protein 
(Alberts et al., 2002) 
 
Proteins are most often fractionated by column chromatography. Since mixtures of proteins 
often are complex, several types of columns are usually employed to produce a highly 
purified protein fraction.  
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2.7.1 Affinity chromatography 
(Ni-NTA His●Bind®Resins Instruction Manual, Novagen) 
 
ParC protein was first purified by affinity chromatography. Affinity chromatography with 
the His●Tag technology is based on the binding between 6 (-10) histidines of the His●Tag 
sequence and an immobilized metal ion, Ni2+-ions (or Cu2+, Zn2+). The histidine tag on the 
recombinant protein interacts with the metal ions and the protein is selectively retained on 
the column. The binding is reversible allowing for elution of the protein with buffers 
containing imidazol. Interaction between resin and his-tag of recombinant protein does not 
depend on tertiary structure and can therefore be purified under native or denaturing 
conditions. Protocols describing the affinity column preparations and purification are listed 
in appendix 19. 
 
2.7.2 Fast Protein Liquid Chromatography  
Gel-filtration chromatography, which separate proteins according to their size and also 
determine the protein size, was the second column used to purify ParC. Gel-filtration was 
preformed with Fast Protein Liquid Chromatography® System (FPLC). The gel filtration 
column (Superdex™ 200 10/300 GL) is formed of cross-linked Agarose matrix which 
attains a highly porous structure and therefore separates the molecules. The largest 
molecules are least withhold in the porous structure, and elution is therefore in order of 
decreasing size.  
 
Molecules excluded from the pores of the stationary phase (100 % in the mobile phase) 
move down the column at the same speed as the mobile phase. They will leave the column 
after one void volume (Vo) of mobile phase has passed through the column. Molecules with 
partial access to the pores will be retarded in their respective degree of access to the pores, 
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and their elution volume (Ve) can be recorded. Molecules with full access to the pores will 
all move down the column at the same speed and remain unseparated from each other. 
 
The molecular weight of molecules in the different elution fractions can be estimated from 
a calibration curve where the Kav values to a set of molecular weight standards have been 
plotted against the logarithm of their corresponding molecular weights. 
 
Kav =  Ve - Vo
           Vt - Vo
 
The fractions containing the desired protein are pooled and dialyzed against an appropriate 
buffer. The protocol describing FPLC is listed in appendix 20.  
 
2.8 Purification of ParC antibody 
 
The purpose of purifying protein ParC was to make a ParC-column. Rabbit IgG to ParC 
was purified on the ParC column after isolation of ParC IgG on the Protein A Sepharose® 
CL-4B column. 
 
A sample of ParC, earlier purified by our group, was injected into a rabbit at Rikshospitalet 
and the antiserum was later collected. Immunoglobulins were first isolated from rest of the 
rabbit antiserum using the immunosorbent Protein A Sepharose® CL-4B. Protein A 
Sepharose is prepared by covalently coupling Protein A to 4 % cross-linked agarose beads. 
Protein A binds to the Fc region (see Figure 7.2) of IgG through interactions with the heavy 
chain. Since only the Fc region is involved in binding, the Fab region (see figure 7.2) is 
available for binding antigen. IgG bound to Protein A was eluted with an acidic glycine 
buffer and the fractions with high ParC IgG content were coupled to a CNBr column. 
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   Fab 
 
 
 
 
 
 
 
Figure 7.2 Immunoglobulin G, built of two heavy chains (blue) and two light chains (yellow), Fc region, 
which binds to the protein A sepharose and Fab, the binding site for antigen. The picture was obtained from: 
http://www.aapsj.org/articles/aapsj0802/aapsj080243/aapsj080243_figure1.jpg
 
To make the ParC column ParC protein was covalently coupled to CNBr activated 
sepharose in a column. Proteins containing primary amino groups can be coupled directly 
to the matrix. The antibodies specific to the antigen ParC, obtained from the protein A 
column, bind to the CNBr column, unreacted sites are blocked with glycin while the 
unbound antibodies and other serum proteins pass through the column. ParC IgG are then 
eluted from the column. Protocols describing preparation of columns and purification are 
listed in appendix 21 and 22. 
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2.9 In vivo characterization of ParC protein 
 
2.9.1 Immunostaining and visualization of stained cells 
(Alberts et al., 2002;Sambrook and Russell, 2001) 
 
Fluorescence microscopy is most often used to detect specific proteins in cells. A widely 
used technique is to couple fluorescent dyes to antibody molecules which then bind 
specifically to antibodies specific for the macromolecule of interest (figure 7.3) 
 
The photons emitted by a dye are of lower energy (longer wavelength) than the photon 
absorbed. The illuminating light is passed through two sets of filters. The first filter lets 
through light with a narrow range of wavelengths that excite the particular fluorescent dye, 
while the second filter blocks out this light and passes only those wavelengths emitted 
when the dye fluoresces. 
 
 
 
 
 
 
 
 
 
Figure 7.3 Fluorescent labeling of a macromolecule by antibodies. Green symbol is macromolecule of 
interest, red symbol is fluorescent dye, 1st Ab is primary antibody specific for macromolecule and 2stAb is 
secondary antibody specific for primary antibody. The picture was obtained from Ingvild Odsbus 
undergraduate thesis, 2003 
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When looking at ParC foci, primary rabbit ParC antibody will bind to ParC in the cell. 
Anti-rabbit IgG labeled with fluorescent sulfoindocyanine dye, Cy3 is added and will bind 
to the primary antibody and give red fluorescence when viewed with the correct filter. 
 
For viewing SeqA foci, the primary anti-SeqA antibody is first purified by incubation with 
cell extract from EBO193 (Δ seqA) that will attract unspecific antibodies, so that only 
specific anti-SeqA antibodies are left in the supernatant collected after centrifugation. The 
supernatant is used as antibody and secondary antibody labeled as described for ParC. DNA 
is labeled with Hoechst 33258 that emits blue light (appendix 24) 
 
2.9.2 Visualization of immunostained cells 
Visualization of immunostained cells was performed using a Zeiss Axioplan2 
phasecontrast/fluorescence microscope equipped with a 63 x objective and a BP546/12 
excitation filter. DNA was visualized with a BP365/12 excitation filter. Pictures were taken 
using a MicroMax CCD camera (Princeton Instruments) that was connected to a 
computerized image analysis system (Axiovision2 Multichannel, Zeiss). The optical 
images, which showed cell outlines, were merged with the fluorescent images, which 
showed fluorescent ParC and SeqA proteins. 
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3.1 Construction of new E. coli ParC overproducer strain 
 
In order to develop a plentiful source for purification, E. coli stain overexpressing ParC via 
T7 RNA polymerase expression system was constructed. The parC gene was first 
subcloned into the plasmid pGEM-T Easy Vector and positive clones were identified by α-
complementation (paragraph 2.3.5). Then the gene was cut out and cloned into the 
expression vector pET-16b behind a T7 promoter that was transformed into a competent E. 
coli strain BL21-Gold(DE3)pLysS. In this strain T7 RNA polymerase is expressed after 
induction with IPTG. 
  
3.1.1 Cloning of parC in E. coli 
Amplification of the gene parC by PCR was tested with the wild type stains MG1655 and 
W3110 as template. This gave no result, but by using the plasmid pIF01 containing parC 
and a primer with his-tag (see below), amplification was carried out.  
 
It was first attempted to clone parC into pET-16b without subcloning. 
 
The parC gene was amplified using the primers ParC F NcoI-His and ParC R BamHI 
(Table A1.3). The parC gene with his-tag and the ParC protein with his-tag will be referred 
to as parC-His and ParC respectively. Both primers contained specific restriction sites 
(underlined, see table A1.3) in the 5`termini that were copied to the termini of the 
complementary DNA sequences. The forward primer; ParC F NcoI contained the restriction 
site NcoI, and the reverse primer, ParC R BamHI contained the BamHI restriction site. The 
amplified DNA fragments were cleaved with the correct restriction enzymes (appendix 7) 
to make DNA fragments with cohesive ends. 
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The expression vector pET-16b was purified from DH5α E. coli cells by small scale DNA 
plasmid purification (appendix 2) and cut with BamHI and NcoI (appendix 7). Both 
restriction sites are situated in the pET-16b cloning region. 
  
After digestion the DNA fragment the plasmid were purified from agarose gel bands as 
described in appendix 5. 
  
A ligation mixture of parC-His and pET-16b was prepared with a molar ratio of insert to 
vector of 2:1 (appendix 7). Electrocompetent cells were prepared from DH5α E. coli cells 
(appendix 8) but electroporation (appendix 9) gave no colonies when the cells were diluted 
and spread on ampicillin containing LB plates. Further, chemically competent cells from 
DH5α E. coli cells, made with CaCl2, were prepared (appendix 10). Transformation of 
recombinant plasmid into the cells (appendix 10) gave negative results.  
  
A comparison of 3 different types of competent cells was carried through (table 3.1). Seven 
different transformation reactions were performed for both electrocompetent and CaCl2- 
competent cells in addition to 2 ligation reactions into Ultracompetent XL10-Gold E. coli 
cells (appendix 11). The first reaction was a control for ampicillin resistance to see if the 
respective cells were able to grow on the plates by themselves. The next four reactions were 
controls where the respective competent cells were transformed with supercoiled plasmid in 
four concentrations to see if the transformation process worked satisfactorily. The final two 
reactions were transformations with the plasmid possibly containing the correct insert, in 
two different concentrations. 
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Table 3.1 Results from comparing transformation of vector pET-16b with parC insert into 
electrocompetent, CaCl2 competent and ultracompetent E. coli cells  
Reaction  Transformation reaction     Transformants 
 
Electrocompetent cells: 
1. Control: ampicillin resistance  Competent DH5α cells            0 
2. Control: transformation  Competent DH5α cells + supercoiled pET16b 100 μl  not countable  
3. Control: transformation  Competent DH5α cells + supercoiled pET16b 10 μl    not countable 
4. Control: transformation  Competent DH5α cells + supercoiled pET16b 1 μl         1060 
5. Control: transformation  Competent DH5α cells + supercoiled pET16b 0.1 μl        177 
6. Ligation   Competent DH5α cells + pET16b with parC-His 10 μl    0 
7. Ligation   Competent DH5α cells + pET16b with parC-His 100 μl   0 
CaCl2 competent cells: 
1. Control: ampicillin resistance Competent DH5α cells           0 
2. Control: transformation  Competent DH5α cells + supercoiled pET16b 100 μl       336 
3. Control: transformation  Competent DH5α cells + supercoiled pET16b 10 μl        34 
4. Control: transformation  Competent DH5α cells + supercoiled pET16b 1 μl           3 
5. Control: transformation  Competent DH5α cells + supercoiled pET16b 0.1 μl        0 
6. Ligation   Competent DH5α cells + pET16b with parC-His 200 μl   0 
7. Ligation   Competent DH5α cells + pET16b with parC-His 800 μl   2  
Ultracompetent cells: 
1. Ligation   Ultracompetent XL10-Gold cells +  
    pET-16b with parC-His 200 μl        0 
2. Ligation   Ultracompetent XL10-Gold cells +  
    pET-16b with parC-His 800 μl      0 
  
  
The electrocompetent and the chemically competent cells gave 106 colonies per μg DNA 
and 103 colonies per μg DNA respectively. Ultracompetent cells should, according to 
producer give 107 colonies per μg DNA. The two positive transformants from reaction 7 
into CaCl2 competent cells were selected (appendix 12). 
  
The possibly recombinant plasmids were purified by small scale DNA plasmid purification 
(appendix 2), digested with the appropriate restriction enzymes (appendix 7), prior to 
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identifying the sizes of the DNA fragments on an agarose gel (appendix 5). The vector was 
found without insert. 
  
Instead of further attempts with almost identical conditions it was decided to try subcloning 
(appendix 13). 
 
The ligation reactions, in two concentrations, of parC-His and pGEM®-T Easy Vector 
(paragraph 2.3.5) were done. The following transformations of recombinant plasmid into 
JM109 High Efficiency Competent Cells, (table 3.2) were performed as described in 
appendix 15. Insertional inactivation of the α-peptide allows recombinant clones to be 
directly identified by color screening on indicator plates (paragraph 2.6) At this stage of 
cloning the control reactions were leaved out since the procedures were known. 
 
Table 3.2 Results from transformation of pGEM-T Easy Vector with parC insert, into JM109 High 
Efficiency Competent E. coli Cells. 
Reaction Transformation reaction    Transformants 
 
1. Ligation JM109 + pGEM-T with parC-His 100 μl     1 white, 6 blue 
2. Ligation JM109 + pGEM-T with parC-His 900 μl     49 white, 41 blue 
  
Positive transformants (white colonies) from both reactions were selected (appendix 12) 
 
To check if the correct fragments had been inserted, the recombinant plasmids were 
purified by small scale DNA plasmid purification (appendix 2) and digested (appendix 7). 
Finally the fragments were identified on a 0.8 % agarose gel where the linearized 
subcloningvector and the parC-His insert constituted 3015 and 2259 base pairs, 
respectively (figure not shown).  
One plasmid construct (# 2.6) was chosen, and identified on a 0.8 % agarose gel a second 
time at 80 V for 2 hours for optimal separation (figure 3.1). 
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1     --------------------  2  ------------------------------- 
 
 
← 3015 bp 
← 2259 bp 
  
  
 
Figure 3.1 Digestion of the pGEM-T Easy Vector with possible parC-His insert 
Lane 1, 2-Log DNA ladder, lanes 2, purified plasmid from positive transformant digested with 
 BamHI and NcoI, possibly containing the parC-His insert. 
 
 
 The plasmid was named pEE1 (figure 3.2). 
 
pEE1
5277 bp
parC-His Ampicillin resistance 
BamHI 
NcoI 
T7
 
 
Figure 3.2 Map of plasmid pEE1 with the insert parC-His inserted into pGEM-T Easy Vector. The plasmid 
is 5277 bp in size and in addition to the parC-His gene the ampicillin gene, the T7 promoter and the 
restriction sites for BamHI and NcoI are indicated. 
 
DNA sequencing was preformed to confirm that the correct fragment had been inserted into 
the plasmid pEE1 during cloning (paragraph 2.4). 
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In order to create the new ParC overproducer strain, the plasmid pEE1 and the expression 
vector pET-16b was purified by large scale purification (appendix 3). The insert parC-His 
was cut out of pEE1 with BamHI and NcoI and ligated into the vector pET-16b which had 
earlier been cut with the same enzymes. The new construct was transformed into 
Ultracompetent XL10-Gold E. coli cells (paragraph 11) and the transformants were selected 
(appendix 12) on LB plates containing 50 µg/ml ampicillin (table 3.3). The control 
reactions were leaved out due to familiarity of the system. 
 
Table 3.3 Results from transformation of vector pET-16b with parC insert into ultracompetent XL10-Gold 
E. coli cells. 
Reaction Transformation reaction              Transformants 
 
1. Ligation Competent XL10-Gold cells + pET 16b with parC-His 100 μl     130 
2. Ligation Competent XL10-Gold cells + pET 16b with parC-His 900 μl    848 
 
Positive transformants from both reactions were selected (appendix 12). 
 
To verify the correct insert, the recombinant plasmids were purified by small scale plasmid 
purification (appendix 2) and digested with BamHI and NcoI (appendix 7). The fragment 
was identified on an agarose gel where the linearized vector and parC-His insert constituted 
5711 and 2259 base pairs, respectively (figure 3.3). 
 
 
 
 
 
 
 
 
 
 
 RESULTS 
 47
 
 1   2     3   4   5    6               1   2    7   8    9  10  11  
  
← 5711 bp 
← 2259 bp 
 
 
Figure 3.3 Digestion of the vector pET-16b with possible parC-His insert. 
Lanes 1, 2-Log DNA ladder, lanes 2, linearized pET16b vector (digested with BamHI and NcoI), lanes 3-11, 
purified plasmid from positive transformants digested with BamHI and NcoI possibly containing the parC-His 
insert. 
  
The plasmid construct in lane 7 was chosen and the plasmid was named pEE2 (figure 3.4). 
 
pEE2
7897 bp
pa rC-HisAmpicillin resistance 
NcoI 
BamHI 
ori  
T7  
  
Figure 3.4 Map of plasmid pEE2 with the insert parC-His inserted into the vector pET-16b. The plasmid is 
7897 basepairs in size and beside the parC-His gene the ampicillin gene, the origin, the T7 promoter and the 
restriction sites for BamHI and NcoI are indicated. 
 
The plasmid pEE2 was purified by large scale purification (appendix 3) for further 
experiments. 
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3.1.2 DNA sequencing and sequence alignment 
DNA sequencing was performed twice during the cloning process to verify that the 
recombinant plasmids had the right insert. Each reaction sequenced only 700 basepairs, so 
parC with 2259 basepairs needed four parallels of recombinant plasmid with one primer for 
each parallel to sequence the whole insert.  
 
To amplify parC the following primers were used:  
- parC F NcoI-His, from basepair 1-620.  
- parC + 542, from basepair 605-1329. 
- parC + 1192, from basepair 1253-1977  
- parC R BamHI, from basepair 1595-2259.  
 
The sequences of the parC insert in both recombinant plasmids were compared to the parC 
gene amplified by using the above-mentioned primers by pairwise alignment (paragraph 
2.4.1). Neither pEE1 nor pEE2 had mutations so the cloning had been successful. 
  
3.2 Expression of ParC protein 
  
The plasmid pEE2 was transformed into BL21-Gold(DE3)pLysS competent E. coli cells 
(appendix 14) and the transformants were selected (appendix 12) and grown overnight in 
LB medium, 50 µg/ml ampicillin and 30 µg/ml chloramphenicol.  
 
3.2.1 Finding conditions for optimal expression of ParC 
It was important to find the optimal expression of ParC protein to get a high benefit from 
the purification. Overnight cultures from transformants of BL21-Gold(DE3)pLysSpEE2 
were diluted 1:10 in LB medium and grown with vigorous shaking at 37ºC for 2 hours. 
Then 0.6 mM or 1 mM IPTG was added to the cultures and the cells were allowed to grow 
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for another 2 ½ hours. Samples for identification by SDS-PAGE (appendix 16 and 17) were 
collected before and after addition of IPTG (figure 3.5 and 3.6).  
  
     1     2      3     4      5                     1     2    3    4    5    6    7    8    9 
 
 
← 80 kDa 
 
 
 
 
Figure 3.5 Samples of uninduced (IPTG) ParC. 
Lane 1, Prescision Plus Protein® Dual Color Standards (marker), lane 2, BL21-Gold(DE3)pLysSpEE2#5, 
lane 3, BL21-Gold(DE3)pLysSpEE2#6, lane 4, BL21-Gold(DE3)pLysSpEE2#7, lane 5, BL21-
Gold(DE3)pLysSpEE2#8. 
   
Figure 3.6 Samples of induced (IPTG) ParC. 
Lane 1, Prescision Plus Protein® Dual Color Standards (marker), lane 2, BL21-Gold(DE3)pLysSpEE2#5 
induced with 0.6mM IPTG, lane 3, BL21-Gold(DE)pLysSpEE2#5 induced with 1 mM IPTG, lane 4, BL21-
Gold(DE3)pLysSpEE2#6 induced with 0.6 mM IPTG, lane 5, BL21-Gold(DE)pLysSpEE2#6 induced with 1 
mM IPTG, lane 6, BL21-Gold(DE)pLysSpEE2#7 induced with 0.6 mM IPTG, lane 7, BL21-
Gold(DE)pLysSpEE2#7 induced with 1 mM IPTG, lane 8, BL21-Gold(DE)pLysSpEE2#8 induced with 0.6 
mM IPTG, lane 9, BL21-Gold(DE)pLysSpEE2#8 induced with 1 mM IPTG 
  
The clone and IPTG concentration (appendix 15) which gave the optimal expression of 
protein ParC, was BL21-Gold(DE)pLysSpEE#7 which was induced with 0.6 mM IPTG. 
The strain BL21-Gold(DE)pLysSpEE2#7 will be referred to as EE3. 
 
The protein appeared at 80 kDa. 
 
To further analyze the protein expression the duration of the IPTG induction time was 
tested. EE3 was induced with 0.6 mM IPTG (appendix 15) for 1, 2 and 3 hours. Samples 
were taken and identified by SDS-PAGE (appendix 16 and 17) (figure 3.7).  
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     1      2      3      4 
 
Figure 3.7 Durations of induced ParC expression. 
Lane 1, Prescision Plus Protein® Dual Color Standards (marker), lane 2, EE3 
induced with 0.6 mM IPTG for 1 hour, lane 3, EE3 induced with 0.6 mM IPTG for 
2 hours, lane 4, EE3 induced with 0.6 mM IPTG for 3 hours. 
 
The optimal duration of induction was 2 hours, which was chosen. 
 
3.2.2 Solubilization of ParC in the extract 
Many proteins are poorly soluble when overproduced and accumulate into inclusion bodies 
(paragraph 2.6.1). To compare the quantity of ParC in the supernatant and the pellet the 
following test was done; an overnight culture IPTG was centrifuged at 16 000 rpm for  
1 minute, and the supernatant was removed. The pellet was resuspended in 1 ml LB 
medium, 20 µl BugBuster, 2 µl Benzonase was added and the samples were identified on a 
SDS- PAGE (appendix 17) (Figure 3.8). 
 
   1     2      3    4     5     6     7 
         
Figure 3.8 ParC protein distributions in inclusion bodies and 
supernatant. Lane 1, Prescision Plus Protein® Dual Color 
Standards (marker), lane 2, 10 μl solution with ParC protein from 
pellet, lane 3, 40 μl solution with ParC protein from pellet, lane 4, 
50 μl solution with ParC protein from pellet, lane 5, 2 μl solution 
with ParC protein from supernatant, lane 6, 5 μl solution with ParC 
protein from supernatant, lane 7, 10 μl solution with ParC protein 
from supernatant. 
 
 
Inclusion body purification was preformed as described in appendix 19. Despite the test 
that verified a higher content of ParC protein in the pellet, and one theoretically should 
believe ParC was easily solubilized, the method was not possible to accomplish in reality 
and therefore left out. 
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3.3 Purification of ParC protein 
 
Purification of ParC protein was done by affinity chromatography and fast protein liquid 
chromatography (FPLC). 
 
Six histidine residues were added to the parC gene during amplification (paragraph 2.3.1) 
which gave rise to a recombinant protein with a His-tag in the N terminal end. This His-tag 
aided the purification process by selective binding to Ni2+ ions that had been charged onto 
to column as described in appendix 19. 
 
3.3.1 Purify protein from supernatant on Ni2+Column 
The lysate-Ni-NTA His-Bind slurry mix was loaded onto the column and the purification 
was preformed with step elution where the imidazole concentration increased in steps from 
10 mM, 20 mM to 40 mM imidazole. Elution was at 250 mM (appendix 19). The fractions 
were identified on SDS-Polyacrylamide gel (figure 3.9). 
 
    1      2      3      4      5      6     7     8     9 
 
 Figur 3.9 Purification of ParC protein on Ni2+Column 
Lane 1, Prescision Plus Protein® Dual Color Standards (marker), lane 2, load - EE3, induced with IPTG 0.6 
mM for2 hour, lane 3,  flow-through during application of sample onto the column, lane 4, wash solution A    
( 20 mM imidazol), lane 5, wash solution B ( 40 mM imidazol), lanes 6-9, elution fractions 1-4 ( 250 mM 
imidazol). 
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The eluation fractions 1 and 2 from the Ni2+- column were pooled and concentrated on a 
Centricon centrifugal filter device.  
  
3.3.2 Purification of ParC on FPLC 
The pooled and concentrated fraction from the nickel column was loaded onto the gel 
filtration column (Superdex 200 10/300 GL) and fast protein liquid chromatography was 
preformed (appendix 20). The protein showed peak elution (elution of protein within a few 
fractions).The peaks were registered and fractions containing the possibly correct protein 
were chosen after estimating their size as explained in paragraph 2.7.2. The estimated size 
in fraction 2 and 9 (figure 3.10) were ~160 kDa which could be explained either from 
possible aggregation of ParC proteins or that ParC was bound to another protein. The 
column was loaded twice due to size of the loop (500 μl), so fractions 2 and 9 both have 
proteins of approximately equal size. The fractions containing the possibly correct protein 
were identified on a SDS-polyacrylamide gel (figure 3.10). 
 
    1        2         3        4         5       6 
     
 
 
← 80 kDa 
← 70 kDa 
 
 
 
 
 
 
 
Figure 3.10 Purification of ParC protein on FPLC. Lane 1, Prescision Plus Protein® Dual Color 
Standards (marker), lane 2, fraction 2; lane 3, fraction 3; lane 4; fraction 8; lane 5, fraction 9; lane 6, 
fraction 10 
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The fractions in lane 2 and 5 (figure 3.10) were combined and dialyzed against 500 ml ice-
cold dialysis buffer for 4 hours and then in 500 ml fresh dialysis buffer overnight. 
 
3.4 Preparing the CNBr-ParC column 
 
In order to remove additives present in the CNBr activated sepharose (paragraph 2.8) from 
producer, the resin was washed at low pH (2-3) (appendix 21) before coupling ParC ligand. 
 
ParC protein, 2.5 mg was diluted in 10 ml coupling buffer and mixed with the washed and 
swelled CNBr resin (appendix 21). Unreacted ParC ligand, if any, is washed away and 
unreacted groups on the resin are blocked. To find out if the protein was completely 
coupled to the CNBr resin the protein concentration in the supernatant was measured. The 
supernatant contained no protein so ParC was almost completely bound to the column. The 
column was stored in 1 M NaCl/0.01% NaN3 at 2-8°C. 
 
3.5 Purification of ParC antibody 
 
As for the CNBr activated sepharose also Protein A Sepharose CL-4B needed to be washed 
to remove additives. After washing and swelling the gel was packed onto the column. 
 
ParC antiserum, obtained from Rikshospitalet after immunization of a rabbit (paragraph 
2.8), was loaded on the protein A column (paragraph 2.8) (appendix 22), and samples from 
flow through, washing and elution were taken for identification on SDS-polyacrylamide gel 
(appendix 17).  
 
Elution fractions with high IgG content from the protein A column were pooled (fractions 
2-11) and mixed with CNBr-ParC resin. The IgG-CNBr-ParC resin was loaded on a 
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column, mixed for 2 hours and eluted with 10 fractions of 0.5 ml. The purified antibody 
was detected by immunoblot analysis (appendix 18). Cell extract for this was made, and 
included in SDS gel electrophoreses at 20 μg per lane (appendix 17). ParC antibody from 
elution faction 2 and elution fraction 3, both from the ParC column (with IgG-CNBr-ParC) 
were diluted 1:200. DnaA antibody, which was included as a positive control for Western, 
was diluted 1:10 000 (figure 3.11). Left membrane was incubated with DnaA antibody, 
middle and right membrane were incubated with ParC antiserum purified against both 
ProteinA column and CNBr-ParC column. 
 
     1      2      3    4     5      6     7            8      9 
  
 
 ←  80 kDa 
 
 
 
 
 
      DnaA ab    ParC ab – elution fr 2   ParC ab – elution fr 3 
 
Figure 3.11 Immunoblot of purified ParC antibody. Lane 1, DnaA protein 10 ng; W3110 wt 20 μg; lane 3 
and 7,  Prescision Plus Protein® Dual Color Standards (marker); lane 4, ParC 10 ng; lane 5, W3110 wt 20 
μg; lane 6, EE3 (op) 20 μg; lane 8, ParC 10 ng; lane 9, W3110 wt 20 μg. 
 
  
After exposing the loaded samples to ParC antibody, and then exposing them to a 
secondary antibody (appendix 24) this is what was used for fluorescence microscopy 
(figure 3.11).  
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3.6 Immunostaining followed by fluorescence microscopy 
 
It has earlier been proposed that ParC localizes as discrete foci on the DNA and between 
the nucleoid masses, and that there is an association between ParC and the replication 
machinery in the cell (Espeli et al., 2003). In addition, earlier observations indicate that 
SeqA interacts with ParC (Kang et al., 2003). I wanted to investigate whether these results 
were reproducible. 
 
Cells from strains MG1655 were grown as described in appendix 16, fixed and stained as 
described in appendix 23. The cells were visualized as described in paragraph 2.9.2. 
 
In W3110 wild type cells immunostained with SeqA, from one and up to 7 foci were 
observed but there were most of two or four fluorescent foci (figure 3.12 b), and in 
accordance with previous results (Molina and Skarstad, 2004). In W3110 wild type cells 
immunostained with ParC antibody discrete fluorescent foci were not observed, instead the 
fluorescence was fairly uniformly distributed (figure 3.12 a).   
a)  
                     
b)  
               
                                
 Figure 3.12 Localization of 
immunostained ParC (a) and 
 SeqA protein (b) in fixed wild type cells.  
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4.1 Localization of the ParC protein 
 
I find here that ParC antibody is not localized as discrete foci, but instead appears 
throughout the cell. This finding indicates that ParC protein does not colocalizes to the 
replication factory. However, this is a negative result and could therefore also be caused by 
a failure to detect intracellular ParC protein properly. A failure to detect ParC could be due 
either to problems with the visualization of ParC itself or with occurrence of signal not 
specific to ParC 
 
There is during the process of my work, an indication that the ParC protein used in serum 
purification is not optimally purified. After running the FPLC gel filtration and identifying 
the samples on SDS-polyacrylamide gel (figure 3.10) there appears a second band just 
beneath ParC. This protein is about 70 kDa. Since Topo IV is a complex of two subunits 
each of the ParC and ParE polypeptides (Peng and Marians, 1993b) and since the active 
form of Topo IV is a heterotetramer, ParC2ParE2, this second band could be ParE. If so, 
ParE would also be present on the serum purification column and antibody against ParE 
would be present in the localization experiments. Par E has been found to be distributed 
uniformly throughout the cell (Espeli et al., 2003), and could therefore explain the result. I 
consider this unlikely, however, because ParC was purified from a strain that overexpresses 
ParC. ParE is not overexpressed and exists only in its native quantity. It is thus not likely 
that the second band is ParE, and likewise unlikely that the cause for the uniform 
fluorescence distribution was detection of ParE. 
 
Another explanation for the second band could be that some of the ParC protein had 
degraded during the purification process. This would give a smaller protein with fewer 
amino acids than ParC. This was tested by running another SDS-PAGE with the same 
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sample after two hours. The gel showed that the protein sizes and the mutual proportions 
were the same as previous. 
 
4.2 Antibody entering the cell 
 
As mentioned above, a problem with the visualization of protein could be due to failure of 
ParC antibody entering the cell during immunostaining.  
Fixation and permeabilization of the cells is necessary for this to happen. 
One major difference between my protocol and Espeli et al (Espeli et al., 2003) was that I 
fixed the bacteria with 77 % ethanol while Espeli fixed with 2.4 % paraformalaldehyd and 
0.01 % glutaraldehyd. The difference in methods could be a reason for the problem with the 
visualization of the protein. 
This explanation is also unlikely since the same protocol was used when fixing and 
immunostaining with SeqA antibody. 
 
4.3 Future plans 
 
The next step in this study would be to vary the conditions for different methods. Due to 
spending much time with cloning there was little time left for this in the end of my study. 
The goal is to make the starting material contain more of what is overexpressed. 
In addition, beside ParC´s possible localization to the replication machinery it wound be 
interesting to find out if ParC has any function there and what it involves. Are the subunits 
of Topo IV distributed in different subcellular locations?  
The likely interaction between SeqA and ParC ought to be further investigated to find out 
more about ParC´s role at the replication factory.  
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Materials 
 
Bacterial strains and plasmids 
Table A1.1 Bacterial strains used in this thesis 
Strain name   Relevant features  Plasmid  Source 
 
BL21-Gold(DE3)pLysS     IPTG, lacUV5  -  Stratagene 
DH5α    recA1, ø80 lac ZΔM15 -  Laboratory stock 
EE3    BL21-Gold(DE3)pLysS pEE2  This work 
JM109 Competent Cells  recA1, lacIqZΔM15 -  Promega    
MG1655   Wild type  -  Guyer et al. -81, Jensen -93 
W3110     Wild type  -  Laboratory stock 
XL10-Gold Ultracompetent cells     X-gal, IPTG, lacZ -  Stratagene 
 
 
Table A1.2 Plasmids used in this thesis 
Plasmid   Relevant features  Selection Source 
 
pEE1   pGEM-T Easy Vector parC-His Amp  This work 
pEE2   pET16b parC-His  Amp, Cam This work  
pET16b   bla, lacI    Amp  Novagen 
pGEM-T Easy Vector bla, lacZ   Amp  Promega 
pIF01   pFH2102 parC   Amp  Flåtten  
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Primers 
Table A1.3 Primers used in this thesis 
Primer   Nucleotide sequence     Producer 
 
ParC F NcoI-His  5`- CGT TA CC ATG GGC CAT CAT CAT CAT  DNA Technology 
   CAT CAC ATG AGC GAT ATG GCA GAG CG - 3`    
ParC R BamHI   5`- CGT CTC TA GGA TCC TTA                          DNA Technology 
 CTC TTC GCT ATC ACC GC TGC- 3`         
parC + 542  5`- GCA TAA CCT GCG TGA AGT GG - 3`       DNA Technology  
parC + 1192  5`- GAA ACC GGC GCT GAT GTC G - 3`       DNA Technology  
 
 
Antibiotics 
Table A1.4 Stock solutions of antibiotics used in this thesis 
Antibiotic  Stock solution    Producer 
 
Ampicillin (Pentrexyl®) 100 mg/ml in dH2O   Bristol-Myers Squibb  
Chloramfenicol  30 mg/ml in CH3COOH   Sigma 
 
 
Enzymes and proteins 
Table A1.5 Restriction enzymes used in this thesis 
Enzym  Restriction site      Buffer   Producer 
  (5´ → 3´) 
 
Bam HI  G/GATCC        NEBuffer for BamHI New England Biolabs Inc. 
NcoI  C/CATGG  NEBuffer 4  New England Biolabs Inc. 
 
 
Table A1.6 Other enzymes and proteins used in this thesis 
Enzym/protein   Buffer    Producer 
 
AmpliTaq polymerase  10 X PCR Buffer   Applied Biosystems 
Anti-Rabbit IgG (whole molecule) Cy3 Conjugate   Sigma 
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Bovine serum albumin (BSA)     New England Biolabs Inc. 
Lysozyme from Chicken Egg White    Sigma| 
Primary rabbit anti-ParC antibody     Department of Cell Biology 
rLysozyme solution 30 KU/μl     Novagen 
Secondary anti-rabbit IgG                                                                Sigma 
T4 DNA ligase (400U/μl) 10 x Buffer for T4 DNA ligase  New England Biolabs Inc. 
 
Markers 
Table A1.7 Markers used in this thesis 
Marker      Producer 
 
2-Log DNA Ladder    New England Biolabs Inc. 
Precision Plus Protein™, Dual Color Standards BioRad   
 
Chemicals 
Table A1.8 Chemicals used in this thesis 
Chemical     Producer 
 
Acetic acid      Merck 
Acrylamide/Bis Solution 30 %   Bio-Rad  
Agarose, Type 1     Sigma 
APS (ammonium persulfate)    Sigma 
β-mercaptoethanol    Stratagene 
Bromophenol blue    Oxoid 
CaCl2      Sigma 
Calf thymus DNA Ultrapure   Sigma 
CH3COOH     Arcus  
Chloroform     Aldrich-Chemie 
Coomassie® brilliant blue R-250   Bio-Rad 
Cyanogen bromide-activated-Sepharose®,   Amersham Pharmacia Biotech 
6 MB (Macrobead     
Decon 90     Decon Laboratories  
Deconex     Decon Laboratories   
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dNTP mix 100mM,    Applied Biosystems   
(dATP, dCTP, dGTP, dTTP)  
DTT (Dithiotreitol)    Sigma 
EDTA (ethylene-diamine-tetra-acetate)  Sigma 
Ethidium bromide 1 % in water   Sigma 
Glucose      Sigma 
Glycerol      Sigma 
Glycin      Sigma 
HCl      Merck 
Hoechst 33258     Sigma 
IPTG, (Isopropyl-β-D-1-thiogalactopyranoside) Sigma 
Isopropanol     Merck 
KCl      Merck 
KH2PO4      Sigma 
Methanol pro analysi    Merck 
Natrium Acetate      Sigma 
NaCl      Sigma  
NaHCO3     Sigma 
Na2HPO4     Merck  
NaOH      Merck 
N2(l)      Aga 
pH calibration solutions  pH 4.005 Radiometer Analytical  
    pH 7.000 Radiometer Analytical  
    pH 10.012 Radiometer Analytical 
Phenol > 5 %     Sigma 
Poly-L-Lysine Solution    Sigma 
Protein A Sepharose® CL-4B   Pharmacia Biotech 
SDS (sodium dodecyl sulfate)   Serva 
Temed N,N,N΄,N΄-Tetra-methyl-ethylenediamine  Bio-Rad  
Tris-hydroxymethyl-aminomethan   Sigma 
Tween® 20     Merck-Schucardt 
X-Gal (5-bromo-4-chloro-3-   Sigma 
indolyl-β-D-galactopyranoside)  
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Commercial products 
Table A1.9 Commercial products used in this thesis 
Product       Producer 
 
BCA Protein Assay Reagent Kit    Pierce 
BugBuster® Ni-NTA His-Bind® Purification Kit  Novagen 
QIAquick® Gel Extraction Kit    QIAGEN 
QIAquick® PCR Purification Kit    QIAGEN 
pGEM-T Easy Vector System II    Promega 
Pure Yield™ Plasmid Midiprep System   Promega 
Wizard®Plus SV Gel and PCR Clean-Up System  Promega 
Wizard®Plus SV Miniprep    Promega 
 
Equipments 
Table A1.10 Equipments used in this thesis 
Equipment   Model    Producer 
 
Balances   Precision Standard   Ohaus Corp. 
    CP 64    Sartorius 
Bio-imazing system  Chemigenius   Synagene 
CCD camera   MicroMax   Princeton Instruments Inc. 
Centrifugal filter devices  Centricon®   Amicon bioseparations 
Centrifuges   Biofuge 13   Heraeus Instruments 
    Eppendorf centrifuge 5417R Eppendorf 
    Galaxy minicentrifuge  VWR International 
    KUBOTA 5900   Kubota Corp. 
    KUBOTA 5910   Kubota Corp. 
    Sorvall RC 5C Plus Rotor  Du Pont Institute  
Cover slip 18 x 18 mm      Assistant 
Cover slip 24 x 24 mm      Assistent 
Dialysis membrane cassette Slide-A-Lyzer®    Pierce 
DNA quantification apparatus   Hoefer® DyNA Quant 200 Amersham Pharmacia Biotech 
Electric power supply  PowerPac 300   BioRad  
    PowerPac 3000   BioRad 
Electrophoresis chamber  Modell B1   OwI Separation Systems, Inc. 
 APPENDIX 1 
 68
Electroporation apparatus Gene Pulser® II     
    Pulse Controller Plus  BioRad 
    Capitance extender  BioRad 
Electroporation cuvette  Gene Pulser® cuvette 0.2 cm BioRad 
End-over-end shaker  Labquake Shaker   Labindustries, Inc. 
Excitation filter for Cy3  BP546/12   Zeiss 
Excitation filter for Hoechst BP365/12   Zeiss 
33258 
Filter paper 3 (immunoblotting) Whatman 3 MM paper  Whatman 
Fluorescence/phase contrast Axioplan 2   Zeiss 
Fluorescenct scanning instrument ChemiGenius2   Syngene 
FPLC apparatus   Gradient Programmer GP-250 Pharmacia Fine Chemicals 
    Pump P-500   Pharmacia Fine Chemicals 
    Fraction Collector Frac-100 Pharmacia Fine Chemicals 
    Single path monitor UV-1  Pharmacia Fine Chemicals 
    Recorder  220 V   Pharmacia Fine Chemicals 
Gelfiltration column  Superdex™ 200 10/300 GL  GE Healthcare 
Heatblock   QBT1    Grant Instruments 
Heatcloset       Termaks 
Laboratory film   Parafilm “M”   American National Can™ 
Lens-cleaning tissue      Assistant 
Lid for Microplate, sterile      Greiner Bio-One   
Magnetstirrer   RCT basic   IKA® Werke 
Microscope slides  Cut edges/frosted end  Menzel-Gläser 
Microwave oven       Sharp 
Microwell plate   PS Microplate 96 well  Greiner Bio-One 
Microwell plate reader  Original Multiscan EX  Labsystems 
Minishaker   MS2 Minishaker   IKA® Works, Inc. 
PCR machine   PTC-100 ™ Programmable MJ Research Inc. 
    Thermal Controller 
    Mastercycler gradient  Eppendorf 
pH- meter   inoLab pH-meter   Semat  
Pipettes    Pipetboy comfort   IBS Integra biosciences 
    Eppendorf   Eppendorf 
Plate scanner   Multiskan EX   Labsystem 
Platform incubator  Thermomixer comfort  Eppendorf 
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Platform shaker   Platform shaker str6  Stuart Scientific 
Polaroid camera   GelCam    Polaroid 
    Electrophoresis hood 0.4 X Polaroid 
    Electrophoresis hood 0.8 X Polaroid 
Polaroid film   667 3 1/4 X 4 1/4  Film-pack Polaroid 
PVDF membrane   Immobilon™-P    Millipore 
Rotors for Sorvall  GS-3    Du Pont Institute 
Semi-dry blotter   Trans-Blot® SD Semi-dry  BioRad 
    transfer cell    
Shaking incubator  Orbital Incubator   Gallenkamp  
Sterile 0.22 μm filter  Express™ PLUS   Millipore 
Spectrophotometer  UV- 160 A   Shimadzu 
UV- illuminator   TFX-20.M   Vilber Lourmat 
Vacuum manifold      Promega 
Water bath   Maxi-shake   Heto 
    Comfort Heto Master Jet  Heto 
    Shaking water bath SBS40 Stuart 
 
Software 
Table A1.11 Software used in this thesis 
Software     Producer 
 
Adobe Acrobat     Adobe Systems Inc. 
Adobe Photoshop CS2     Adobe Systems Inc. 
AxioVision version 3.0.6    Zeiss 
AxioVision Image Viewer    Zeiss      
BioEdit Sequence Alignment Editor 
GeneSnap     Synoptics Ltd. 
Gene Tools     Synoptics Ltd. 
Microsoft Office Excel 2003   Microsoft 
Microsoft Office Powerpoint 2003   Microsoft 
Microsoft Office Word 2003   Microsoft 
Reference Manager Version 11   ISI ResearchSoft 
Vector NTI Advance 10    Invitrogen 
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Growth media 
 
LB (Luria-Bertani) 
Tryptone      10 g 
Yeast extract          5 g 
NaCl       10 g 
dH20               to 1000 ml 
 
Low salt LB contain 5 g NaCl 
Adjust pH to 7.0 with NaOH and then autoclave. 
 
LB Agar 
Tryptone      10 g 
Yeast extract          5 g 
NaCl       10 g 
Agar       20 g 
dH20                        to 1000 ml 
 
Adjust pH to 7.0 with NaOH and then autoclave. 
Pour into Petri dishes (~25 ml/100-mm plate) 
 
AB Minimal medium  
 
5xA  
(NH4)2SO4      2 g 
Na2HPO4      6 g 
KH2PO4       3 g 
NaCl       3 g 
dH2O                                   to 200 ml 
 
B   
0.1 M CaCl2                 1 ml 
1.0 M MgCl2                 1 ml 
0.003 M FeCl3                 1 ml 
Autoclaved H2O                      to 800 ml 
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5xA and B were mixed. This gave AB. 
1 ml 1 mg/ml thiamine was added to AB. This made ABBB1. 
 
ABB1 was supplemented with: 
 
0.2 % glucose 
0.5 % CAA 
100 μg/ml uridine.        
 
Buffers and solutions 
 
TE-buffer (~pH 8) 
Tris-HCl              10 mM 
EDTA                   1 mM 
 
Agarose gel electrophoresis  
 
5 x TBE buffer 
Tris base      54 g 
Boric acid                           27,5 g 
0.5 M EDTA                              20 ml 
dH2O           to 1000 ml 
 
The agarose gels were run in 0.5x TBE buffer. 
 
Agarose gel loading buffer 
87 % glycerol                 500 μl 
dH2O                               500 μl 
Bromophenolblue                            0,03 % 
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Coomassie staining solutions 
 
Coomassie 
Coomassie Brilliant Blue R-250     2.5 g 
Methanol               455 ml 
dH2O                455 ml 
Acetic acid                   90 ml  
 
40 % methanol/ 20 % acetic acid 
Methanol               400 ml 
Acetic acid               200 ml 
dH2O                400 ml 
     
Proteinmåling 
 
BSA Std 2 mg/ml 
Coomassie Plus Protein Assay Reagent 
 
 
DNA quantification buffer 
 
10 x TNE buffer 
Tris base      100 mM 
EDTA        10 mM 
NaCl          2    M 
 
10 x TNE buffer was diluted to 1 x TNE buffer and added 1:10000 1 mg/ml Hoechst 33258 
 
Gel filtration buffer 
 
GF buffer 1 
Tris-HCl pH 7.66 (v/5°C)      20 mM 
EDTA       0.2 mM 
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GF buffer 2 
Tris-HCl pH 7.66 (v/5°C)      20 mM 
EDTA       0.2 mM 
NaCl          0.5 M 
 
Immunostaining 
 
PBS buffer 
5 M NaCl          7 ml 
4 M KCl                 125 μl  
0.1 M Na2HPO4                      20 ml 
1 M KH2PO4                    375 μl 
dH2O                 to 250 ml 
 
PBS-T contained 0.05 % Tween 
 
 
 
Lysozyme solution 
30 mg/ml lysozyme    133 μl  
1 M Tris-HCl       50 μl 
50 μl % glucose       36 μl 
0.5 M EDTA         4 μl 
dH2O     to         2000 μl 
 
Mounting medium antifade 
1 M PBS     20 μl 
87 % glycerol                460 μl 
1 mg/ml Hoechst 33258      5 μl 
dH2O     to       1000 μl 
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Protein purification buffers under denaturing conditions 
 
 
1 M NaH2PO4/ Na2HPO4   pH 8 
1 M NaH2PO4                 6.8 ml 
1 M Na2HPO4               93.2 ml 
 
1 M NaH2PO4/ Na2HPO4   pH 6.3 
1 M NaH2PO4                82.2 ml 
1 M Na2HPO4                17.8 ml 
 
1 M NaH2PO4/ Na2HPO4   pH 5.9 
1 M NaH2PO4                92.1 ml 
1 M Na2HPO4                  7.9 ml 
 
1 M NaH2PO4/ Na2HPO4   pH 4.5 
1 M NaH2PO4                98.0 ml 
1 M Na2HPO4                  2.0 ml 
 
 
 
Denaturing lysis/bind buffer - Buffer B 
Urea                 48.05 g 
1 M NaH2PO4/ Na2HPO4   pH 8   10 ml 
1 M Tris- HCl  pH 8      1 ml 
dH2O              to 100 ml 
 
Denaturing wash buffer - Buffer C 
Urea                 48.05 g 
1 M NaH2PO4/ Na2HPO4   pH 6.3   10 ml 
1 M Tris- HCl  pH 6.3      1 ml 
dH2O              to 100 ml 
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Denaturing elution buffer - Buffer D 
Urea                 48.05 g 
1 M NaH2PO4/ Na2HPO4   pH 5.8   10 ml 
1 M Tris- HCl  pH 5.8      1 ml 
dH2O              to 100 ml 
 
Denaturing elution buffer - Buffer E 
Urea                 48.05 g 
1 M NaH2PO4/ Na2HPO4   pH 4.5   10 ml 
1 M Tris- HCl  pH 4.5      1 ml 
dH2O              to 100 ml 
 
Due to the dissociation of urea, the pH of Buffers B, C, D and E should be adjusted immediately prior to use. 
 
Dialyse Buffer with 4 M Urea 
Urea               240.24 g 
1 M Tris-HCl pH 7.5    50 ml 
0.5 M EDTA       2 ml 
1 M DTT       5 ml 
5 M NaCl     40 ml 
99 % Glycerol                 300 ml 
dH2O            to 1000 ml 
 
Dialyse Buffer with 2 M Urea 
Urea               120.12 g 
1 M Tris-HCl pH 7.5    50 ml 
0.5 M EDTA       2 ml 
1 M DTT       5 ml 
5 M NaCl     40 ml 
99 % Glycerol                 300 ml 
dH2O            to 1000 ml 
 
Dialyse Buffer without Urea 
Similar to native conditions 
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Protein purification buffers under native conditions 
 
1 M NaH2PO4/ Na2HPO4   pH 8 
1 M NaH2PO4                 6.8 ml 
1 M Na2HPO4               93.2 ml 
 
Bind Buffer 
NaCl               876 mg 
1 M NaH2PO4/ Na2HPO4   pH 8              2.5 ml 
Imidazol                           34.4 mg 
dH2O              to 50 ml 
 
Wash Buffer A 
NaCl               876 mg 
1 M NaH2PO4/ Na2HPO4   pH 8              2.5 ml 
Imidazol                      68.8 mg 
dH2O              to 50 ml 
 
Wash Buffer B 
NaCl               876 mg 
1 M NaH2PO4/ Na2HPO4   pH 8              2.5 ml 
Imidazol                         137.6 mg 
dH2O              to 50 ml 
 
Elution Buffer 
NaCl               876 mg 
1 M NaH2PO4/ Na2HPO4   pH 8              2.5 ml 
Imidazol                            860 mg 
dH2O              to 50 ml 
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Dialyse Buffer 
1 M Tris-HCl pH 7.5    50 ml 
0.5 M EDTA       2 ml 
1 M DTT       5 ml 
5 M NaCl     40 ml 
99 % Glycerol                 300 ml 
dH2O            to 1000 ml 
 
Coupling buffer 
0.1 M NaHCO3      
0.5 M NaCl 
pH 8.3-8.5 
 
SDS-polyacrylamide gel electrophoresis 
 
2 x SDS gel sample buffer 
5 % Bromophenol blue    0.4 ml 
1 M Tris-HCl pH 6.5    1.0 ml 
1 M DTT     2.0 ml 
Glycerol 99 %                2.02 ml 
10 % SDS     4.0 ml 
dH2O                 0.58 ml 
 
1.5 M Separation gel buffer 
Tris base     182 g 
HCl          to pH ~ 8.8 
dH2O           to 1000 ml 
 
0.5 M Stacking gel buffer 
Tris base      61 g 
HCl         to pH ~ 6.8 
dH2O         to 1000 ml 
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Separation gel solution (10 %) 
dH2O      2.0 ml       
Separation gel buffer               1.25 ml 
Acrylamide/Bis Solution (30 %)   1.7 ml 
10 % SDS       50 μl 
10 % APS      25 μl 
TEMED      2.5 μl 
 
Stacking gel solution (4 %) 
dH2O                  875 μl 
Stacking gel buffer                400 μl 
Acrylamide/Bis Solution (30 %)               200 μl 
10 % SDS     16 μl 
10 % APS       8 μl 
TEMED                                1.6 μl 
 
Running buffer 1 % 
10 % SDS                20 ml 
10 X Running buffer             200 ml 
dH2O             1780 ml 
 
 
Immunoblot analysis buffers 
 
Anode buffer I 
Tris base     36.3 g 
Methanol                 200 ml 
dH2O         to    1000 ml 
 
 
Anode buffer II 
Tris base     3.03 g 
Methanol                200  ml 
dH2O         to    1000 ml 
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Cathode buffer 
6-amino-n-hexanoic acid    5.2 g 
Methanol               200 ml 
dH2O         to  1000 ml 
 
5xTBS-buffer 
1 M Tris- HCl (pH7.5)    50 ml 
NaCl                    146 g 
dH2O           to  1000 ml 
 
TBS-T contained 0.05 % Tween. 
 
 
Small scale DNA plasmid purification solutions 
 
Alkaline lysis solution I 
Glucose      50 mM 
Tris- HCl (pH 8.0)    25 mM 
EDTA (pH 8.0)     10 mM 
 
Alkaline lysis solution II 
NaOH        0.2 M 
SDS             1 % 
 
Alkaline solution II should be freshly prepared. 
 
Alkaline lysis solution III 
Potassium acetate 5M    60 ml 
Acetic acid                        11.5 ml 
dH2O                   to 100 ml 
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Protocols for standard DNA techniques 
 
Small scale DNA plasmid purification 
Small scale DNA plasmid purification was performed using Wizard® Plus SV Minipreps 
DNA Purification Systems (Promega) 
(Product instructions for Wizard® SV Plus Minipreps DNA Purification Systems, 
Promega) 
  
1.  4.5 ml of an overnight (12-16 hours) culture grown in LB medium, containing  
     50 μg/ml ampicillin and 30 μg/ml chloramphenicol, was centrifuged at maximum             
 speed (13 000 rpm) for 1 minute. The supernatant was removed and the tube was 
 inverted on a paper towel to remove excess media. 
2. 250 μl Cell Resuspension Solution was added and the cell pellet resuspended 
 thoroughly by pipetting and vortexing. 
3. 250 μl Cell Lysis Solution was added and the tube was inverted 4 times to mix the 
 solution. The tube was incubated 1-5 minutes until the solution was clear. 
4.  10 μl Alkaline Protease Solution was added, mixed by inverting the tube  
 4 times and incubated for 5 minutes. 
5. 350 μl Neutralization Solution was added, the tube inverted 4 times and the 
 solution centrifuged at maximum speed for 10 minutes. 
6. The Spin Column was inserted into a Collection Tube. The cleared lysate was 
 transferred carefully to the prepared Spin Column by decanting.  
7. The supernatant was centrifuged at maximum speed for 1 minute. The Spin 
 Column was removed from the tube, the flowthrough was discarded and the Spin 
 Column was reinserted into the Collection Tube. 
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8. 750 μl Wash Solution was added to the Spin Column. The solution was 
 centrifuged at maximum speed for 1 minute, the Spin Column removed and the 
 flowthrough discarded. Spin Column was reinserted into the Collection Tube. 
9. The wash procedure was repeated using 250 μl Wash Solution. The solution was 
 centrifuged at maximum speed for 2 minutes. 
10. The Spin Column was carefully transferred to a new sterile centrifuge tube. 
11. Plasmid DNA was eluted by adding 100 μl of Nuclease-Free Water to the Spin 
 Column. The column was centrifuged at maximum speed for 1 minute. 
12.  After the plasmid DNA was eluted the Spin Column was discarded.  
13. The DNA concentration was measured as described in paragraph 2.2.3 
14. The purified plasmid DNA was stored at -20 ◦C. 
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Large scale DNA plasmid purification  
Large scale DNA plasmid purification was performed using PureYield™ Plasmid Midiprep 
Systems (Promega) 
(Product instructins for Pure Yield™ Plasmid Midiprep Systems, Promega) 
 
1. 50 ml of an overnight culture grown in LB medium, containing  
50 μg/ml ampicillin and 30 μg/ml chloramphenicol, was centrifuged at 6 000 rpm 
 for 10 minutes. The supernatant was removed and the tube was inverted on a 
 paper towel to remove excess media. 
2. The cells were resuspended in 3 ml Cell Resuspension Solution. 
3. 3 ml Cell Lysis Solution was added, the tube gently inverted 3-5 times and then 
 incubated at room temperature for 3 minutes. 
4. 5 ml Neutralization Solution was added to the lysed cells and the tube was inverted 
 5 times. The tube was incubated 2-3 minutes in an upright position to allow a 
 white flocculent precipitate to form. 
5. The lysate was poured into the PureYield™ Clearing Column and incubated for  
 2 minutes to allow the cellular debris to rise to the top. 
6. The lysate was centrifuged in a swinging bucket rotor centrifuge at 1 500 x g for  
 5 minutes. The tube should not be capped during centrifugation.  
7.    A PureYield™ Binding Column was placed into a vacuum manifold 
8. The lysate was poured into the binding column and applied maximum vacuum. 
 The vacuum was continued until all the liquid had passed through the binding 
 column. 
9. The vacuum was slowly released from the binding column. 
10. 5.0 ml of Endotoxin Removal Wash was added to the binding column, and the 
 solution was pulled through the binding column by vacuum. 
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11. 20 ml of Column Wash Solution was added to the binding column and the  solution 
 was pulled through the binding column by vacuum. 
12. The membrane was dried by applying a vacuum for 30 seconds. 
13. The binding column was removed from the vacuum manifold and tapped on a 
 paper towel to remove excess ethanol. Excess ethanol was wiped from the outside 
 of the tube and the binding column was placed into a new 50 ml disposable plastic 
 tube. 
14. 600 μl of Nuclease-Free water was added to the DNA binding column. The 
 binding column was centrifuged in a swinging rotor centrifuge at 1 500 x g for 5 
 minutes and the filtrate collected. 
15. The purified DNA solution was stored at -20°C 
16  The DNA concentration was measured as described in paragraph 2.2.3 
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Purification of DNA from gel bands 
Purification of DNA from gel bands was preformed using QIAquick® Gel Extraction Kit 
(QIAGEN) and Wizard® SV Gel and PCR Clean-Up System (Promega) 
(Product instructions for QIAquick® Gel Extraction Kit (QIAGEN) and Wizard® SV Gel 
and PCR Clean-Up Systems (Promega)) 
 
QIAquick® Gel Extraction Kit 
 
1. An empty 1.5 ml eppendorf tube was weighed and the weight was recorded. 
2. The DNA fragment was excised from the agarose gel with a clean scalpel. Extra 
 agarose was minimized around the DNA band by cutting and the slice was 
 transferred to the pre-weighed eppendorf tube. 
3. The gel sliced was weighed in the tube and the weight of the empty tube was 
 subtracted to determine the weight of the slice. The maximum amount of gel slice 
 per QIAquick® column was 400 mg. 
4. 3 volumes of Buffer QG were added to 1 volume of gel slice. 
5. The eppendorf tube was closed and incubated at 50°C for 10 minutes until the gel 
 was completely dissolved.  
6. A QIAquick® spin column was placed in a provided 2 ml collection tube. 
7. The sample was transferred to the QIAquick® column, and centrifuged at 13 000 
 rpm for 1 minute at room temperature. 
8.  The flow-through was discarded and the QIAquick® column was placed back in 
 the same collection tube. 
9.  To remove all traces of agarose 0.5 ml Buffer QG was added to QIAquick® 
 column and centrifuged for 1 minute at room temperature. 
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10. 0.75 ml of Buffer PE was added to QIAquick® column to wash. The sample was 
 incubated 2 minutes before it was centrifuged at 13 000 rpm for 1 minute at room 
 temperature. 
11. The flow-through was discarded and the QIAquick® column centrifuged for an 
 additional 1 minute at 13 000 rpm. 
12. The collection tube was discarded and the QIAquick® column was placed into a 
 clean 1.5 ml eppendorf tube. 
13. To elute the DNA, 30 μl of autoclaved H2O was applied to the center of the 
 QIAquick® membrane. 
14.  The sample was incubated at room temperature for 1 minute. 
15. The sample was centrifuged at 13 000 rpm at room temperature for 1 minute. 
16. The sample was stored at -20°C.  
  
Wizard® SV Gel and PCR Clean-Up System 
 
1. Following electrophoresis, The DNA band was excised from the agarose gel and 
 placed in a pre-weighed eppendorf tube.  
2. The tube with the gel sliced was weighed, the weight of the tube subtracted and  
 10 μl Membrane Binding Solution was added per 10 mg of gel slice.  
3. The tube was vortexed and incubated at 50°C until the gel slice was completely 
 dissolved.  
 For PCR reactions an equal volume of Membrane Binding Solution was added. 
4. SV Minicolumn was inserted into Collection Tube. 
5. The dissolved gel slice or the PCR product was transferred to the Minicolumn 
 assembly, and incubated for 1 minute at room temperature.  
6. The sample was centrifuged at 13 000 rpm for 1 minute at room temperature. The 
 flowthrough was discarded and the Minicolumn reinserted into Collection Tube. 
7. 700 μl Membrane Wash Solution was added and centrifuged at 13 000 rpm for  
 1 minute at room temperature. The flow-through was discarded and the 
 Minicolumn reinserted into Collection Tube. 
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8. Step 7 was repeated with 500 μl Membrane Wash Solution and centrifuged at 
 13 000 rpm for 5 minutes at room temperature. 
9. The Collection tube was emptied and the column assembly was recentrifuged for   
 2 minutes to allow evaporation of residual ethanol. 
10. The Minicolumn was transferred to a clean 1.5 ml eppendorf tube. 
11. 50 μl of Nuclease-Free water was added to the Minicolumn, incubated at room 
 temperature for 1 minute and centrifuged at 13 000 rpm for 1 minute. 
12. The Minicolumn was discarded the DNA stored at -20°C. 
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Agarose gel electrophoresis 
(Sambrook and Russell, 2001) 
 
1. The specified amount of powdered agarose was weighed and solved in 50 or 60 
 ml 0.5 x TBE-buffer. The solution was heated in a microwave until the agarose 
 dissolved. 
2. The warm gel solution was poured into the mold, and the appropriate comb 
 positioned for forming the sample slots in the gel. 
3. The gel was allowed to set completely (30-45 minutes at room temperature), the 
 comb was removed and the gel mounted in the electrophoresis tank filled with 
 enough 0.5 x TBE buffer to cover the gel. 
4. The DNA samples and the DNA marker were mixed with the desired gel-loading 
 buffer, and slowly loaded into the slots.  
5. The gels were run at 90-100 V until the samples had migrated a sufficient distance 
 through the gel. 
6. The gel was stained by immersing it in H2O containing EtBr, for 30-45 minutes in 
 room temperature, in a dark room. 
7. The DNA was visualized with UV light and photographed with a Polaroid  camera 
 or with GeneSnap 
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The polymerase chain reaction (PCR) 
 
1. 4 μl of an overnight culture (pIF01) grown in LB was added to 96 μl PCR mix 
 containing 1 x PCR buffer, 200 μM dNTP, 2 pM primer ParC F NcoI, and primer 
 ParC R BamHI and 5 U Ampli Taq Gold. 
2. The PCR reaction was carried out after the following program: 
 
  Initial Denaturation (Hot start) 94ºC    2 minutes 
  Denaturation    94ºC   30 seconds ⎫ 
  Annealing    60ºC  30 seconds ⎬ 30 cycles 
  Synthesis    68ºC   2 minutes  ⎭ 
  Extension    68ºC   5 minutes 
 
3.  The PCR product was identified on a 1 % agarose gel as described in appendix 5, 
 and the DNA was purified as described in appendix 4. 
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Digestion of DNA by restriction nucleases 
1. 1-10 μg of purified plasmid DNA or PCR product was mixed with the appropriate 
 10 x reaction buffer diluted to 1 x reaction buffer with dH2O. BSA was added to a 
 final concentration of 100 μg/ml. 
2. 5-20 U/μg DNA of restriction nucleases was added to 50-100 μl reaction mixture. 
3. The sample was thoroughly mixed by pipetting up and down and shortly spinned to 
 collect the sample in the bottom of the tube. 
4. The sample was incubated at 37ºC for 2-3 hours. 
5. The restriction nuclease, NcoI was inactivated at 65ºC for 20 minutes. BamHI 
 could not be inactivated. 
6. The digested fragments were run on a 0.8 % agarose gel as described in appendix 5  
 and purified as described in appendix 4. 
   
       
Ligation 
1. The amplified DNA insert and the plasmid vector were digested with restriction 
 nucleases as described in paragraph 2.3.2 and mixed in a molar ratio of 2:1 in 10 x 
 T4 ligase buffer diluted (with dH2O if necessary) to 1 x ligase buffer to a total 
 reaction volume of 20 μl. 
2. 1 μl T4 DNA ligase (400 U/ μl was added to the reaction mixture. 
3. The reaction mixture was incubated at 16ºC over night. 
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Preparation of electrocompetent cells 
1. 3 x 1 ml ON culture of DH5α cells was made 
2.  ON culture was diluted 1:100 in 320 ml low-salt LB in a 2.5 l bottle. The cells 
 were grown until OD600 reached 0.8 with vigorous shaking at 37ºC. 
3.  The cells were transferred to 50 ml centrifuge bottles and placed on ice for 15-30 
 min. The bottles were centrifuged at 4 000 rpm for 15 minutes at 4°C 
4. The media was removed and the cells resuspended in 400 ml cold dH2O. The 
 bottles were centrifuged at 4 000 rpm for 15 minutes at 4°C. 
5. The media was removed and the cells resuspended in 200 ml cold dH2O. The 
 bottles were centrifuged at 4 000 rpm for 15 minutes at 4°C. 
6. The media was removed and the cells resuspended in 8 ml 10 % cold glycerol. 
 The bottles were centrifuged at 4 000 rpm for 15 minutes at 4°C. 
7. The media was removed and the cells resuspended in 2.4 ml 10 % cold glycerol. 
 (Used twice as much glycerol due to “tett kultur”) 
8.  The cell mixture was divided in aliquots of 100 μl in eppendorf tubes and frozen at 
 -80°C. 
 
 APPENDIX 9
APPENDIX 9 
                            
    
91 
 
Electroporation 
1. The cells were thawed carefully and kept on ice. 
2. 1-2 μl DNA was added and mixed well. The mixture was kept on ice for 1 minute. 
3. Gene Pulser™ Apparatus settings were adjusted to:  
  Capacitance:  25 μF  
  Voltage:  2.5 kV  
  Pulse Controller:  400 Ω 
4. The mixture of electrocompetent cells and DNA was transferred to a cold 0.2 cm 
 Gene Pulser Cuvette and put in the cuvette holder. The holder was pushed into the 
 chamber between the electrodes. 
5. The pulse was started by pushing both the red knob on the Gene Pulse Apparatus 
 simultaneously until a beep sound was heard. This gave a pulse of 4-5 msec. and 
 field strength of 12.5 kV/cm. 
6. The cuvette was removed from the chamber and 1 ml LB medium was added to 
 the cuvette immediately. The cells were resuspended with a pasteur pipette, and 
 transferred to a 15 ml sterile plastic tube. Then the cells were incubated at 37 °C 
 for 1 hour with agitating. 
7. 10 μl and 100 μl were spread on LB agar plates containing 50 μg/ ml ampicillin. 
8. The plates were incubated at 37°C over night for colony formation. 
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Preparation of chemically competent cells using CaCl2
1. 2 x 1 ml LB medium was inoculated with DH5α and grown ON at 37°C with 
 agitating. 
2. 0.5 ml ON culture was inoculated with 25 ml fresh LB. 
3. When OD600 reached 0.3 the tube was put on ice for 10 minutes. 
4. The tube was centrifuges at 5 000 rpm for 10 minutes at 4°C. 
5. The supernatant was discarded and the cells resuspended in 1 ml ice-cold 
 CaCl2/glycerol [0.1M/15%] 
6. The cells were placed on ice for 30 minutes or more (the longer the better) 
7. The cell mixture was divided in aliquots of 200 μl in eppendorf tubes.  
8. The cells were frozen at -80°C. 
  
 
Transformation of chemically competent cells (CaCl2) 
1. The cells were thawed on ice. 
2. 4 μl ligation mixture was added to 200 μl competent cells. 
3. The mixture was placed on ice for 30 minutes. 
4. The tube was heat-pulsed at 42°C for 90 sec, and then placed on ice for 2 minutes. 
5. 0.8 ml LB was added and incubated at 37°C for 45-60 minutes. The tube was 
 vigorously shaken. 
6. The mixture was spread on LB agar plate containing 50 μg/ml ampicillin. 
7. The plate was incubated at 37°C overnight.  
8. Positive transformants were selected as described below in appendix 12 and kept in 
 glycerol stocks at -80°C for further use. 
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Transformation of “ultra-competent” cells 
1. A 14 ml Falcon tube was pre-chilled on ice. LB medium was preheated to 42°C. 
2. The cells were thawed on ice, gently mixed and 100 μl of cells were put in the 
 tube. 
3. 4 μl β-ME mix (β-mercaptoethanol) was added to the cells 
4. The tube was swirled gently and the cells were incubated on ice for 10 minutes, 
 swirling gently every 2 minutes. 
5. 2 μl ligation mixture was added to the cells, and the tube was swirled and 
 incubated on ice for 30 minutes. 
6. The tube was heat-pulsed in a 42°C water bath for 30 seconds.  
7. The tube was incubated on ice for 2 minutes. 
8. 0.9 ml of preheated LB medium was added and the tube incubated at 37°C for 1 
 hour with shaking at 225-250 rpm. 
9. The transformation mixture was plated on LB agar plate containing ampicillin 
 50 μg/ml and chloramphenicol 30 μg/ml. 
10. The plate was incubated at 37°C overnight.  
11. Positive transformants were selected as described in below in appendix 12 and 
 kept in glycerol stocks at -80°C for further use. 
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Selection of transformants 
1. 4-5 colonies were picked from the LB agar plates and each colony was inoculated  in 
 6 ml LB medium containing appropriate antibiotics, and incubated with vigorous 
 shaking at 37°C over night. 
2. Small scale DNA plasmid purification was performed on possibly positive 
 transformants as described in appendix 2. 
3. The samples were digested with restriction enzymes as described in appendix 7, and 
 identified by agarose gel eletrophoresis as described in appendix 5. 
4. Positive transformant were selected and kept in glycerol stocks at -80°C for 
 further use. 
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Subcloning 
1.  The pGEM®T-Easy Vector tube was briefly centrifuged to collect the content at the 
bottom of the tube. 
2. A ligation reaction was set up: 
 
 2 x Rapid Ligation Buffer, T4 DNA Ligase 5 μl 
pGEM®T Easy Vector  (50 ng)  1 μl 
PCR product (120 ng)    1 μl 
T4 DNA Ligase (3 Weiss units/μl)  1 μl 
Deionized water to a final volume of            10 μl 
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Transformation of protein expression cells 
(Product instruction for BL21-Gold(DE3)pLysS Competent Cells (Stratagene)) 
 
1. The cells were thawed on ice. 
2.  A 14 ml Falcon tube was prechilled on ice and 100µl of the competent cells were 
gently mixed and added to the tube. 
3. 50 ng of DNA was added to the transformation reaction and gently swirled. 
4. The reaction was incubated on ice for 30 minutes. 
5. LB medium was preheated in a 42ºC water bath. 
6. The reaction was heat-pulsed in a 42ºC water bath for 20 seconds exactly. 
7. The reaction was incubated on ice for 2 minutes. 
8.  0.9 ml of preheated LB medium was added and the reaction was incubated at 37ºC 
for 1 hour with shaking at 225-250 rpm. 
9.  The reaction was plated onto LB plates with 50 µg/ml ampicillin and 30µg/ml 
chloramphenicol. 
10. The plates were incubated at 37ºC overnight. 
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Induction of target protein using IPTG 
(Product instruction for BL21-Gold(DE3)pLysS Competent Cells (Stratagene)) 
 
1. 1 ml LB medium containing 50 µg/ml ampicillin and 30 µg/ml chloramphenicol was 
inoculated with single colonies from the transformation. 
2. Next morning, 50 µl of each culture was inoculated into fresh LB medium 
containing no antibiotics. These cultures were incubated with shaking at 220-250 
rpm at 37ºC for 2 hours. 
3. 100 µl of each of the cultures were pipetted into clean micro centrifuge tubes and 
placed on ice until needed for gel analysis. These served as the non-induced control 
samples. 
4. To the rest of the culture in each tube IPTG was added to a final concentration of  
0.6 mM or 1 mM. The cultures were incubated with shaking at 220-250 rpm at 37ºC 
for 2 hours. 
5. The cultures were centrifuged at 16 000 rpm for one minute. The supernatant was 
removed and the cell pellet frozen at -20ºC for 15-20 minutes. 
6. Cell pellets were thawed and solved in 100 µl BugBuster. 2.5 U benzonase was 
added and the sample was incubated at room temperature for 10 minutes. 
7. The samples were centrifuged at 16 000 rpm for 10 minutes and the supernatants 
were transferred to clean tubes. 
8. The supernatants were compared on SDS- gel (appendix 17). 
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Preparation of cell extract for SDS-PAGE  
1. Cells from an overnight culture were grown to OD600 = 0.15 in LB or OD450 = 0.15 
in AB minimal medium supplemented with 1μg/ml thiamine, 0.2 % glucose, 0.5 % 
casamino acids and 100 μg/ml uridine. 
2. 10 ml of exponentially growing cells were centrifuged at 8 500 rpm for 5 minutes at 
4°C. 
3. The supernatant was removed and the pellet resuspended in 150 μl resuspension 
buffer. 
4. The cells were lyzed at 98°C for 5 minutes. 
5. The cells were stored at 4°C. 
 
 
Measurement of total protein content 
1. A set of diluted albumin BSA standards were prepared; 0 mg/ml, 0.5 mg/ml, 1.0 
mg/ml, 1.5 mg/ml and 2.0 mg/ml, from 2.0 mg/ml BSA stock standard in the same 
diluent as the extract samples. 
2. 10 µl of diluted BSA standards and 10 µl of cell extract samples were added to the 
appropriate microwell plate wells. 
3. 200 µl of BCA Reagent A and BCA Reagent B (50:1) were added to each well and 
mixed well with a pipette tip.  
4. The plate was covered and incubated at 37ºC for 30 minutes. 
5. The plate was cooled to room temperature. 
6. The absorbance was measured at 570 nm on a microwell plate reader. 
7. A standard curve was made by plotting the absorbance for each BSA standard versus 
its concentration in µg/ml. 
8. By using standard curve, the protein concentration of each unknown sample was 
determined. 
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Preparation of SDS polyacrylamide gel and samples, and running the gel 
1. Two glass plates were washed with 70 % ethanol and dH2O and dried. 
2. The glass plates were assembled together and the separation gel solution (10%) was 
poured on top, in between the glass plates. 
3. 1 ml dH2O was added to the top of the solution. 
4. After polymerization was complete (~ 30 minutes), dH2O was removed, and 
stacking gel solution (4%) was poured on top of the polymerized separation gel. 
5. A 1.0 mm comb was immediately inserted into the stacking gel solution. 
6. After polymerization was completed (~ 30 minutes), the comb was removed and the 
wells washed with dH2O to removed any unpolymerized acrylamide. 
7. The gel was mounted into the electrophoresis chamber. 
8. Running buffer 1% was added to the top and bottom reservoirs. 
9. A SDS-PAGE marker and samples were mixed with the appropriate amount of 2 x 
SDS gel-loading buffer, heated for 5 minutes at 98ºC and loaded into the wells. 
10. The rest of the top reservoir of the electrophoresis chamber was completely filled 
with running buffer 1%. 
11. The electrophoresis apparatus was attached to an electric supply and the gel was run 
at a constant voltage of 150 V for 1-1 ½ hours. 
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Detection of proteins by immunoblot analysis 
1. The PVDF membrane was cut in the correct size and the hydrophobic surface of the 
membrane was wet with methanol and then soaked in dH2O for about 15 minutes. 
2. 6 Whatman 3MM papers were cut in the correct size and saturated with the 
appropriate transfer buffer; 2 papers in Anode buffer I, 1 paper in Anode buffer II 
and 3 papers in Cathode buffer. 
3. The saturated Whatman 3MM papers, the saturated PVDF membrane and the gel 
were placed in the semidry blotting apparatus in the in the following order relatively 
to each other; Anodebuffer I – Anodebuffer II – PVDF-membrane – gel – Cathode 
buffer. The membrane was placed underneath the gel facing the anode. 
4. The semidry blotting apparatus was attached to an electric power supply and run at 
15 V for 30-60 minutes. 
5. The membrane was soaked in low-fat dried milk dissolved in TBS-T for at least 60 
minutes with slow shaking in room temperature or overnight at 4ºC. 
— 
6. The primary antibodies; anti-SeqA and ParC were diluted 10 000 fold and 200 fold, 
respectively in 15 ml low-fat dried milk dissolved in TBS-T. 
7. The membrane was incubated with the primary antibody for 2 hours with slow 
shaking. 
8. The membrane was washed 4 x 5 minutes with TBS-T. 
9. The secondary antibody (anti-rabbit IgG) was diluted 10 000 fold in 15 ml low-fat 
dried milk dissolved in TBS-T. 
10. The membrane was incubated with the secondary antibody for 2 hours with slow 
shaking. 
11. The membrane was washed again as in step 8. 
12. The washed blot with the protein-side up was placed on a clean glass plate. 
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13. 1 ml ECF substrate was added and the membrane was kept in a dark place for 5 
minutes. Then the membrane was transferred to a Whatman 3MM paper to dry in the 
dark for another 30 minutes. 
14. The membrane was scanned and viewed using GeneSnap software. 
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Preparation of cell lysate for Ni2+-column  
1. 15 ml LB containing 50 μg/ml ampicillin and 30 μg/ml chloramphenicol was 
 inoculated with the strain EE3. The culture was grown at 37°C with constant 
 shaking for 15-16 hours.  
2. The overnight culture were centrifuged at 6 000 rpm for 10 minutes at 4ºC (Sorvall, 
GS-3 rotor). The supernatant was removed and the pellets resuspended in 2 000 ml 
LB, 50 μg/ml ampicillin and 30 μg/ml chloramphenicol. The culture was grown to 
OD600 ~ 0.6 with constant shaking. 
3. At OD600 ~ 0.6, 0.6 mM IPTG was added, and the culture allowed to grow for 
 another 120 minutes. 
4. The cells were harvested by centrifugation at 6 000 rpm for 10 minutes at 4◦C 
 (Sorvall, GS-3 rotor). 
5. The supernatant was removed and the pellets frozen at -20◦C. 
6. The frozen cells were thawed on ice and completely resuspended in 40 ml room 
 temperature BugBuster Protein Extraction Reagent by pipetting. 40 μl Benzonase 
 Nuclease was added. The cell suspension was incubated on ice for 10 minutes. 
7. The cell suspension was centrifuged at 3 000 rpm for 20 minutes at 4◦C. The pellet 
was saved for inclusion body purification as described below. The supernatant was 
used as lysate in the protocol underneath. 
 
Preparation of Ni2+-column and purification under native conditions 
(The procedure was carried out in a cold room) 
 
1. 1 ml of 50 % Ni-NTA His•Bind® slurry was added to 4 ml of Bind Buffer and 
 mixed  gently in a Falcon tube. 
2. The resin was allowed to settle by gravity and 4 ml of the supernatant was removed 
 with a pipette. 
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3. The cleared lysate from the protocol above was added to the Ni-NTA His•Bind® 
slurry and mixed gently at 4◦C for 60 minutes at an end-over-end shaker. 
4. The lysate-Ni-NTA His•Bind® mixture was loaded into a column with the bottom  
 outlet capped. 
5. The bottom cap was removed and the column flow-through was collected.  
6. The column was washed with 4 ml Wash Buffer A. The buffer was loaded on 
 gently. 
7. The column was washed with 4 ml Wash Buffer B. 
8. The protein was eluted with 4x 0.5 ml Elution Buffer. 
9. The flow-through, wash fractions and eluate were analyzed on SDS-PAGE as in 
 paragraph 17. 
10. The elution-fractions with most protein were dialyzed against 500 ml Dialyze 
 Buffer  overnight at 4◦C with stirring. The protein was further dialyzed the next day 
 for 6 hours in another 500 ml Dialyze Buffer.  
 
Preparation of Ni2+-column and purification under denaturing conditions 
(The procedure was carried out in a cold room) 
 
1. The cell pellet from the preparation of cell lysate (appendix 19) was resuspended in  
4 ml BugBuster Protein Extraction Reagent and mixed by pipetting up and down to 
obtain an even suspension. Thorough resuspension of pellet is critical to obtain a 
high purity inclusion body preparation. The inclusion body pellet was completely 
dispersed during BugBuster wash steps in order to solubilize and remove 
contaminating proteins from the pellet. 
2. rLysozyme Solution was added to a final concentration of 1 KU/ml. The mixture 
 was vortexed and incubated at room temperature for 5 minutes. 
3. 10 volumes of BugBuster reagent diluted 1:10 (= 40 ml) in deionized water was 
 prepared. 
4. 6 volumes (= 24 ml) diluted BugBuster reagent was added to the suspension and 
 vortexed for 1 minute. 
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5. The inclusion bodies were harvested by centrifugation at 5 000 x g for 15 minutes at 
 4◦C and the supernatant was removed with a pipette. 
6. The inclusion bodies were resuspended in 12 ml diluted BugBuster, mixed by  
 vortexing and centrifuged at 5 000 x g for 15 minutes at 4◦C. This wash step was 
repeated twice. The inclusion bodies were resuspended once more but centrifuged at 
16 000 x g for 15 minutes at 4◦C, and the supernatant removed. 
7. The final pellet of purified inclusion bodies was resuspended in denaturing 
lysis/bind buffer; Buffer B 
8. 1 ml of 50 % Ni-NTA His•Bind® slurry was added 4 ml of denaturing lysis/bind 
Buffer B and mixed gently in a Falcon tube. 
9. The resin was allowed to settle by gravity and 4 ml of the supernatant was removed 
with a pipette. 
10. 4 ml of lysate from step 7 was added to the Ni-NTA His•Bind® slurry and mixed 
gently at 4◦C for 60 minutes at an end-over-end shaker. 
11. The lysate-Ni-NTA His•Bind® mixture was loaded into a column with the bottom 
outlet capped. 
12. The bottom cap was removed and the column flow-through was collected.  
13. The column was washed with 4 ml denaturing wash buffer; Buffer C twice. The 
buffer was loaded on gently. 
14. The protein was eluted with 2x0.5 ml denaturing elution buffer; Buffer D. 
15. The protein was eluted with 2x0.5 ml denaturing elution buffer; Buffer E. 
16. The flow-through, wash fractions and eluate were analyzed on SDS-PAGE as in 
paragraph 17. 
17. The elution-fractions with most protein were dialyzed against 500 ml Dialyze Buffer 
with 4 M Urea overnight at 4◦C with stirring. The protein was further dialyzed the 
next day for 4 hours in 500 ml Dialyze Buffer with 2 M Urea and finally in 500 ml 
Dialyze Buffer without Urea. 
18. The ParC protein was frozen at -20◦C.  
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Preparation of gel column and running FPLC apparatus 
1. A syringe filled was filled with dH2O, the stopper was removed and the syringe was 
connected to the column. 
2. The twist off end was removed and the column was washed with 1 ml dH2O. 
3. The gel column was connected to the apparatus and the UV detector 
4. The dialyzed ParC protein was thawed on ice and spun down at 16 000 rpm for 10 
minutes at 4ºC, to remove aggregates. 
5. The sample was concentrated on a Centricon® Centrifugal filter device and 
carefully loaded onto the column using a loop. The sample loop had to be full to 
avoid air getting onto the column. 
6.  The column was washed with GF buffer. The ParC protein was eluted and collected 
in fractions according to the recorded peaks on the print. 
7. The fractions containing the greatest amounts of purified protein were detected by 
SDS-PAGE (appendix 17) 
 
 
 
 
 APPENDIX 21
APPENDIX 21 
                            
    
106 
 
Preparation of ParC-CNBr column  
1. 300 mg CNBr activated sepharose was washed and swelled in 4 x 15 ml ice-cold  1 
mM HCl for at least 30 minutes. 
2. The solution was shaken and the supernatant was removed by gentle suction. 
3. The resin was washed with 20 ml dH2O and resuspended in 1 ml dH2O.  
4. The ParC protein (2.5 mg) was diluted in 10 ml coupling buffer and mixed with the 
CNBr resin. 
5. The mixture of protein and gel was shaken at room temperature for 2 hours. 
6. The supernatant was removed and unreacted ligards were washed away with 3 x 10 
ml coupling buffer. 
7. Unreacted sites were blocked with 10 ml 0.2 M Glycin pH 8 (in coupling buffer) for 
2 hours at room temperature.   
8. The blocking solution was removed away by washing alternately 0.1 M NaAcetate 
buffer pH 4 containing 0.5 M NaCl and 0.1 M NaAcetate buffer pH 8 containing 0.5 
M NaCl. 
9. This wash cycle was completed four times. 
10. Wash with 50 mM Tris pH 7. 
11. If the column was not to be used immediately it was stored in 1 M NaCl/0.01 % 
NaN3 at 4°C. 
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Purification of ParC antibody 
1. 1.5 g Protein A Sepharose CL-4B was suspended in dH2O. The swollen gel was 
washed for 15 minutes with further 300 ml dH2O. 
2. The gel was poured on the column and equilibrated with binding buffer, 50 mM Tris 
pH 7.0. 
3. 6 ml ParC antiserum was thawed and centrifuged at 13 000 rpm for 10 minutes. 
4. The supernatant was poured on the column and the flow-through was collected. 
5. The column was washed with 20 ml binding buffer and 4 x 5 ml wash fractions were 
collected. 
6. The column was eluted with 5 ml 0.1 M glycine pH 3.0 and 12 elution fractions 
were collected. 
7. Samples were taken from the fractions and ran on a SDS- polyacrylamide gel and 
stained with Commassie. 
8. The eluted fractions with high IgG content were pooled and neutralized with 1 M 
Tris pH 9. 
9. The ParC-CNBr column was equilibrated with 50 mM Tris pH 7. 
10. The IgG solution from step 8 was centrifuged and the supernatant was mixed with 
the ParC-CNBr resin from appendix 21 and shaken on an end-over-end shaker for  
2 hours.  
11. The mixture was poured on the column and the flow-through was collected. 
12. The column was washed with 20 ml 50 mM Tris pH 7 in 5 ml fractions. 
13. The column was eluted with 5 ml 0.1 M Glycine pH 3.0 in 0.5 ml fractions. 
14. Samples were taken from the fractions and ran on a SDS-polyacrylamide gel and 
 stained with Commassie.  
15. The eluted fractions with high IgG content were pooled and neutralized with 1M 
 Tris pH 9 
16. The specificity of the antibody was checked on a Western gel against ParC protein. 
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Fixation of cells for microscopic studies 
 
1. 2 x 1.5 ml of exponentially growing cells were put on ice. 
2. The cells were harvested by centrifugation at 10 000 rpm for 2 minutes at 4°C. 
3. The supernatant was removed, and the pellet was resuspended in 1 ml ice-cold, 
 filtered (0.22 μm) TE buffer. 
4. The suspension was centrifuged at 10 000 rpm for 2 minutes at 4°C. 
5. 100 μl supernatant was left for resuspension of the cells. 
6. 1 ml ice-cold, filtered (0.22 μm) 77 % ethanol was added and the sample was stored 
 at 4°C for several months. 
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Immunostaining 
 
Absorption of unspesific antibody  
1. EBO 193 (ΔseqA) cell extract was spun down in order to move aggregates. 
2. SeqA antibody was diluted 200 times with cell extract to a final volume of 50 μl. 
3. 6 μl PBST with 10 mM EDTA was added and incubated on ice for 1 hour. 
4. The supernatant was collected by centrifugation at 15 000 for 15 minutes at 4°C. The 
supernatant was used as antibody. 
 
Staining fixed cells with antibody 
 
1. An overnight culture was diluted 1:500 in 25 ml desired medium to OD = 0.15. 
2. 2 x 1.5 ml of culture was collected by centrifugation at 13 000 rpm for 3 minutes at 
4°C. 
3. The supernatant was removed and the pellet resuspended in 1 ml in 1 ml ice-cold 
filtrated (0.22 μm) TE buffer. 
4. The suspension was centrifuged at 13 000 rpm for 3 minutes at 4°C. 
5. The supernatant was removed except 100 μl which was left for resuspension of the 
cells. 
6. 1 ml ice-cold filtrated (0.22 μm) 77 % ethanol was added and stored at 4°C for 
several months. 
7. A glass slide was cleaned with Decon 90, destilled water and 70 % ethanol. 20 μl 1 
mg/ml poly-L-lysine was dropped on the slide, incubated for 5 minutes, washed with 
dH2O and air-dried. 
8. 10 μl fixed cells were taken from the bottom of the eppendorf tube, added to the 
glass slide in a thin layer and air-dried. 
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9. To remove excess of cells the slide was washed with dH2O and air-dried. 
10. The dried area was covered with 100 μl of lysozyme solution and incubated at room 
temperature for 5-10 minutes. 
11. The slide was covered with 1 ml PBST for 30 seconds and inclined to remove the 
solution. This step was repeated 3 times. 
12. The slide was covered with 1 ml 99 % methanol for 1 minute and inclined. The slide 
was air-dried. 
13. 50 μl PBS-T with 2 % BSA was added for 15 minutes to the area for blocking and 
the glass slide was inclined to remove the solution against a paper. 
14. 20 μl antibody (anti-SeqA, see above or ParC from elution fraction 2, see appendix 
22 and figure 3.11) was covered with a cover slip and incubated at room temperature 
for 1 hour in a moisture chamber. 
15. The cover slip was removed and the glass slide washed 10 times with 1 ml PBS-T. 
The remaining solution was removed against a paper. 
16. 50 μl PBS-T with 2 % BSA was added for 15 minutes and the glass slide was 
inclined to remove the solution. 
17. 20 μl Cy3-anti rabbit IgG (500 folded) was added; covered with a cover slip and 
incubated at room temperature in a dark room for 1 hour in a moisture chamber. 
18. The cover slip was removed and the glass slide washed 10 times with 1 ml PBS-T. 
The remaining solution was removed against a paper. 
19. 20 μl Mounting medium with antifade for staining of DNA was added and covered 
with a cover slip. 
20. The glass slide was kept at 4°C. 
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Amino acid and nucleotide sequence of the parC gene 
 (the GenBank accession number is M58408) 
(http://www.ebi.ac.uk/cgi-bin/dbfetch?db=embl&id=M58408&style=raw) 
 
 
ID   M58408; SV 1; linear; genomic DNA; STD; PRO; 2284 BP. 
AC   M58408; M37832; 
DT   17-NOV-1990 (Rel. 25, Created) 
DT   17-APR-2005 (Rel. 83, Last updated, Version 4) 
DE   E.coli topoisomerase IV subunit (parC) gene, complete cds. 
KW   ParC protein; topoisomerase IV subunit. 
OS   Escherichia coli 
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales; 
OC   Enterobacteriaceae; Escherichia. 
RN   [1] 
RP   1-2284 
RX   DOI; 10.1016/0092-8674(90)90172-B. 
RX   PUBMED; 2170028. 
RA   Kato J.-i., Nishimura Y., Imamura R., Niki H., Hiraga S., Suzuki 
H.; 
RT   "New topoisomerase essential for chromosome segregation in E. 
coli"; 
RL   Cell 63(2):393-404(1990). 
FH   Key             Location/Qualifiers 
FH 
FT   source          1..2284 
FT                   /organism="Escherichia coli" 
FT                   /strain="K-12" 
FT                   /sub_strain="W3110" 
FT                   /mol_type="genomic DNA" 
FT                   /db_xref="taxon:562" 
FT   CDS             92..2284 
FT                   /codon_start=1 
FT                   /transl_table=11 
FT                   /gene="parC" 
FT                   /product="topoisomerase IV subunit" 
FT                   /db_xref="GOA:P0AFI2" 
FT                   /db_xref="PDB:1ZVT" 
FT                   /db_xref="PDB:1ZVU" 
FT                   /db_xref="UniProtKB/Swiss-Prot:P0AFI2" 
FT                   /protein_id="AAA24297.1" 
 /translation="MYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTV 
 GDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLS 
 KYSELLLSELGQGTADWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNL 
 REVAQAAIALIDQPKTTLDQLLDIVQGPDYPTEAEIITSRAEIRKIYENGRGSVRMRAV 
 WKKEDGAVVISALPHQVSGARVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRS 
 NRVDMDQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRL 
 NYRLEKVLKRLHILEGLLVAFLNIDEVIEIIRNEDEPKPALMSRFGLTETQAEAILELK 
 LRHLAKLEEMKIRGEQSELEKERDQLQGILASERKMNNLLKKELQADAQAYGDDRRSPL 
 QEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKS 
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 NQPVVFVDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHMLMESDDQKLLMAS 
 DAGYGFVCTFNDLVARNRAGKALITLPENAHVMPPVVIEDASDMLLAITQAGRMLMFPV 
 SDLPQLSKGKGNKIINIPSAEAARGEDGLAQLYVLPPQSTLTIHVGKRKIKLRPEELQK 
 VTGERGRRGTLMRGLQRIDRVEIDSPRRASSGDSEE" 
XX 
SQ   Sequence 2284 BP; 548 A; 571 C; 672 G; 493 T; 0 other; 
gcgaataagt tgaggaatca gaattaatga gcgatatggc agagcgcctt gcgtacatga    60 
atttacggaa aacgcctact taaactactc catgtacgtg atcatggacc gtgcgttgcc   120 
gtttattggt gatggtctga aacctgttca gcgccgcatt gtgtatgcga tgtctgaact   180 
gggcctgaat gccagcgcca aatttaaaaa atcggcccgt accgtcggtg acgtactggg   240 
taaataccat ccgcacggcg atagcgcctg ttatgaagcg atggtcctga tggcgcaacc   300 
gttctcttac cgttatccgc tggttgatgg tcaggggaac tggggcgcgc cggacgatcc   360 
gaaatcgttc gcggcaatgc gttacaccga atcccggttg tcgaaatatt ccgagctgct   420 
attgagcgag ctggggcagg ggacggctga ctgggtgcca aacttcgacg gcactttgca   480 
ggagccgaaa atgctacctg cccgtctgcc aaacattttg cttaacggca ccaccggtat   540 
tgccgtcggc atggcgaccg atattccacc gcataacctg cgtgaagtgg ctcaggcggc   600 
aatcgcatta atcgaccagc cgaaaaccac gctcgatcag ctgctggata tcgtgcaggg   660 
gccggattat ccgactgaag cggaaattat cacttcgcgc gccgagatcc gtaaaatcta   720 
cgagaacgga cgtggttcag tgcgtatgcg cgcggtgtgg aagaaagaag atggcgcggt   780 
ggttatcagc gcattgccgc atcaggtttc aggtgcgcgc gtactggagc aaattgctgc   840 
gcaaatgcgc aacaaaaagc tgccgatggt tgacgatctg cgcgatgaat ctgaccacga   900 
gaacccgacc cgcctggtga ttgtgccgcg ttccaaccgc gtggatatgg atcaggtgat   960 
gaaccacctc ttcgctacca ccgatctgga aaagagctat cgtattaacc ttaatatgat  1020 
cggtctggat ggtcgtccgg cggtgaaaaa cctgctggaa atcctctccg aatggctggt  1080 
gttccgccgc gataccgtgc gccgccgact gaactatcgt ctggagaaag tcctcaagcg  1140 
cctgcatatc ctcgaaggtt tgctggtggc gtttctcaat atcgacgaag tgattgagat  1200 
cattcgtaat gaagatgaac cgaaaccggc gctgatgtcg cggtttggcc ttacggaaac  1260 
ccaggcggaa gcgatcctcg aactgaaact gcgtcatctt gccaaactgg aagagatgaa  1320 
gattcgcggt gagcagagtg aactggaaaa agagcgcgac cagttgcagg gcattttggc  1380 
ttccgagcgt aaaatgaata acctgctgaa gaaagaactg caggcagacg cgcaagccta  1440 
cggtgacgat cgtcgttcgc cgttgcagga acgcgaagaa gcgaaagcga tgagcgagca  1500 
cgacatgctg ccgtctgaac ctgtcaccat tgtgctgtcg cagatgggct gggtacgcag  1560 
cgctaaaggc catgatatcg acgcgccggg cctgaattat aaagcgggtg atagcttcaa  1620 
agcggcggtg aaaggtaaga gcaaccaacc ggtagtgttt gttgattcca ccggtcgtag  1680 
ctatgccatt gacccgatta cgctgccgtc ggcgcgtggt cagggcgagc cgctcaccgg  1740 
caaattaacg ttgccgcctg gggcgaccgt tgaccatatg ctgatggaaa gcgacgatca  1800 
gaaactgctg atggcttccg atgcgggtta cggtttcgtc tgcaccttta acgatctggt  1860 
ggcgcgtaac cgtgcaggta aggctttgat caccttaccg gaaaatgccc atgttatgcc  1920 
gccggtggtg attgaagatg cttccgatat gctgctggca atcactcagg caggccgtat  1980 
gttgatgttc ccggtaagtg atctgccgca gctgtcgaag ggcaaaggca acaagattat  2040 
caacattcca tcggcagaag ccgcgcgtgg agaagatggt ctggcgcaat tgtacgttct  2100 
gccgccgcaa agcacgctga ccattcatgt tgggaaacgc aaaattaaac tgcgcccgga  2160 
agagttacag aaagtcactg gcgaacgtgg acgccgcggt acgttgatgc gcggtttgca  2220 
gcgtatcgat cgtgttgaga tcgactctcc tcgccgtgcc agcagcggtg atagcgaaga  2280 
gtaa                                                               2284 
// 
 
 
 
 
 
 
